Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer, August 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 412 articles:
HTML format


 

Single Articles

  1. ANDERSSON M, Zewdie BN, Mumena C, Thulin EA, et al
    Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.
    Sci Rep. 2026;16:23719.
    PubMed    
    Abstract available

  2. PANG X, Liu T, Xin J, Li W, et al
    Serotonin transporter acts as a tumor suppressor in cervical cancer.
    Cell Signal. 2026 Jul 31:112771. doi: 10.1016/j.cellsig.2026.112771.
    PubMed    
    Abstract available

  3. SHARMA M, Kumar D, Kumar M, Bassi P, et al
    QbD-driven formulation development and evaluation of apigenin loaded chitosan-tethered in-situ cubosomal gel for the management of cervical cancer: A preclinical study.
    Int J Biol Macromol. 2026 Jul 31:153834. doi: 10.1016/j.ijbiomac.2026.153834.
    PubMed    
    Abstract available

  4. SIULUTA N, Deaterly C, Villalba K, Scaglione NM, et al
    Association of sexual trauma and demographic characteristics with cervical cancer screening among women with HIV.
    AIDS Care. 2026 Jul 31:1-10. doi: 10.1080/09540121.2026.2706231.
    PubMed    
    Abstract available

  5. PRIYANKA B, Gurjar B, Dahiwade S, Narayan G, et al
    Comparative Performance of Pap Smear and Colposcopy in Cervical Cancer Screening Among Women With Abnormal Cervical Findings in Central India: A Prospective Observational Study.
    Health Sci Rep. 2026;9:e72881.
    PubMed    
    Abstract available

  6. ARROYO MUHR LS, Dillner J
    Challenges and possible solutions towards reaching global cervical cancer elimination.
    EClinicalMedicine. 2026;97:103890.
    PubMed    
    Abstract available

  7. KHAN NG, Adiga D, Sanjay KU, Rai PS, et al
    Bisphenol A disrupts mitochondrial homeostasis and promotes metabolic alterations in cervical cancer cells.
    Environ Sci Pollut Res Int. 2026 Jul 30. doi: 10.1007/s11356-026-38082.
    PubMed    
    Abstract available

  8. LIAO L, Zeng L, Zhao Y, Guo Z, et al
    OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer.
    Oncogene. 2026 Jul 30. doi: 10.1038/s41388-026-03909.
    PubMed    
    Abstract available

  9. KOLINA AD, Oleynikova NA, Andreeva YY, Danilova NV, et al
    [The effect of storage duration on the preservation of DNA and the feasibility of genetic studies in formalin-fixed paraffin-embedded tissue samples].
    Arkh Patol. 2026;88:35-40.
    PubMed    
    Abstract available

  10. AHUJA S, Jainar CJE, Moufarrij S, Dee EC, et al
    Global Disparities in Current Clinical Trials in Cervical Cancer.
    JAMA Netw Open. 2026;9:e2626173.
    PubMed    


  11. LUO D, Sharman AR, Bateson D, Smith M, et al
    Gynaecologists' Views and Acceptability of Active Surveillance for Women Diagnosed With Cervical Intraepithelial Neoplasia 2: A Qualitative Study.
    Aust N Z J Obstet Gynaecol. 2026;66:e70165.
    PubMed    
    Abstract available

  12. HUANG H, Li P, Zhu L, Wu Y, et al
    RNA-Binding Protein RBMS3 Inhibits Cervical Cancer Progression by Enhancing HSPA6 mRNA Stability.
    Front Biosci (Landmark Ed). 2026;31:51761.
    PubMed    
    Abstract available

  13. MBELWA H, Leo J, Kahesa C, Munema A, et al
    BiCervi: Pap smear microscopy image dataset for cervical cancer detection and classification.
    Data Brief. 2026;68:113077.
    PubMed    
    Abstract available

  14. HUANG L, Lin N, Li H, Hu Y, et al
    Spatially organized macrophage-T-cell crosstalk in cervical cancer: insights from single-cell and spatial omics.
    Front Immunol. 2026;17:1896004.
    PubMed    
    Abstract available

  15. CURRIER JJ, Van Houweling E, Bolten K, Wasson N, et al
    Female allogeneic hematopoietic cell transplant survivors' perspectives on cervical cancer screening: a retrospective study.
    Support Care Cancer. 2026;34:814.
    PubMed    
    Abstract available

  16. POLTEN R, Kutle I, Stalp JL, Hachenberg J, et al
    Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.
    Sci Rep. 2026;16:23557.
    PubMed    
    Abstract available

  17. YANG H, Yang W, Tian H, Chang Y, et al
    Multi-modal Stacking Machine Learning Model for Predicting Lymph Node Metastasis in Cervical Cancer.
    Acad Radiol. 2026 Jul 29:S1076-6332(26)00530-1. doi: 10.1016/j.acra.2026.
    PubMed    
    Abstract available

  18. WU N, Lin F, Ji J, Pan H, et al
    Retraction notice to "Mitochondrial oxidative stress related LncRNA predict cervical cancer prognosis and immunotherapy response: Molecular structure and protein interaction of ribosomal protein L34" [Int. J. Biol. Macromol. 299 (2025) 140145].
    Int J Biol Macromol. 2026 Jul 29:153730. doi: 10.1016/j.ijbiomac.2026.153730.
    PubMed    


  19. SCHRODER C, Qureischi M, Hecking T, Nadal J, et al
    Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer.
    Anticancer Res. 2026;46:4371-4383.
    PubMed    
    Abstract available

  20. WILSON A, Cropper A, Ma Y, Adams EJ, et al
    Improving laboratory workforce efficiency using AI-assisted digital cytology within an HPV-based cervical screening programme: A model-based evaluation for the NHS Cervical Screening Programmes.
    BMJ Open. 2026;16:e113298.
    PubMed    
    Abstract available

  21. MIN S, Zhu Y, Xie L, Zhang H, et al
    TCTP regulates the infiltration of CXCR4+ immunosuppressive cells in cervical Cancer via the non-canonical NF-kappaB/ZEB1/CXCL12 Axis.
    Cell Signal. 2026 Jul 29:112761. doi: 10.1016/j.cellsig.2026.112761.
    PubMed    
    Abstract available

  22. ZHANG P, Tong X, Chen X, Feng Y, et al
    Changes in HPV vaccine hesitancy and influencing factors among female university students in China: A national repeated study.
    Hum Vaccin Immunother. 2026;22:2701549.
    PubMed    
    Abstract available

  23. SWISHER EM, Davis M, Rubin-Saika M, Manhardt E, et al
    Cervical Cancer Screening With Human Papillomavirus Self-Collection Testing in an Opioid Treatment Program.
    JAMA Netw Open. 2026;9:e2625993.
    PubMed    
    Abstract available

  24. ZHENG X, Wang W, He C, Wang L, et al
    LncRNA DNM3OS suppresses proliferation, invasion, and epithelial-mesenchymal transition in cervical cancer cells via miR-454-3p.
    Mol Biol Rep. 2026;53:1300.
    PubMed    
    Abstract available

  25. SILVA ERPHD, Gubert VT, Puga MAM, Tozetti IA, et al
    Cervical cancer screening in incarcerated women: deprived of freedom or deprived of health?
    Rev Bras Enferm. 2026;79:e20250011.
    PubMed    
    Abstract available

  26. CHANG H, Liu X, Qin L, Wang Y, et al
    An explainable machine learning approach for cervical cancer screening: decoding morphological diagnostic drivers.
    Acta Clin Belg. 2026 Jul 29:1-13. doi: 10.1080/17843286.2026.2711062.
    PubMed    
    Abstract available

  27. UTAMI TW, Nuranna L, Purwoto G, Oktalia A, et al
    Unveiling Optimal Cervical Cancer Screening Age Range: Study of HPV Infection Among 75,719 Women in Indonesia's Metropolitan Regions (2012 - 2022).
    Asian Pac J Cancer Prev. 2026;27:2541-2548.
    PubMed    
    Abstract available

  28. KAUR SD, Dwivedi R, Nalwa A, Dwivedi P, et al
    Awareness of and Barriers to Cervical Cancer Screening among Married Tribal Women in Sirohi, Rajasthan: A Community-based Study.
    Asian Pac J Cancer Prev. 2026;27:2457-2465.
    PubMed    
    Abstract available

  29. CHEN Y, Xie Y, Wu J, Qu X, et al
    Mucus and tumor penetrating paclitaxel micelles for potent local therapy of cervical cancer.
    J Nanobiotechnology. 2026;24:700.
    PubMed    
    Abstract available

  30. OGURA J, Sato S, Koshida Y, Kasuga M, et al
    HPV18-Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights.
    J Obstet Gynaecol Res. 2026;52:e70426.
    PubMed    
    Abstract available

  31. DALABEHERA M, Chaudhari S, Kumar J, Poonia N, et al
    Mechanistic advances in nanomedicine, nucleic acid therapies, and AI-driven research on cervical cancer.
    J Pharm Sci. 2026 Jul 28:104442. doi: 10.1016/j.xphs.2026.104442.
    PubMed    
    Abstract available

  32. ZHANG M, Wang N, Liu X, Wang Y, et al
    STING-engineered biomimetic hybrid membrane nanovaccine for enhanced immunotherapy of cervical cancer.
    Colloids Surf B Biointerfaces. 2026;268.
    PubMed    
    Abstract available

  33. XIAO C, Huang C, Lin W, Tian F, et al
    Improving CT-CBCT deformable image registration for cervical cancer adaptive radiotherapy using a deep learning approach.
    Front Oncol. 2026;16:1855718.
    PubMed    
    Abstract available

  34. GUIMARAES JMN, Pescarini JM, Moncayo AL, Craig P, et al
    Racial inequities in cervical cancer mortality and the role of the Bolsa Familia conditional cash transfer programme: results from the 100 Million Brazilian Cohort.
    Lancet Reg Health Am. 2026;62:101562.
    PubMed    
    Abstract available

  35. KOLAMBKAR S, Tomar M, Arif N, Hussain S, et al
    HPV vaccination in the WHO South-East Asia Region: A scoping review of uptake, implementation challenges, and pathways to acceleration.
    Hum Vaccin Immunother. 2026;22:2693359.
    PubMed    
    Abstract available

  36. YILIHAMU Y, Zhang X, Zhao Z, Aili M, et al
    Tumor microenvironment-activated HA@GOx/IR-820@MnO(2) nanosheets for dual-modal imaging guided phototherapy of cervical cancer.
    J Mater Chem B. 2026 Jul 28. doi: 10.1039/d6tb01062.
    PubMed    
    Abstract available

  37. GONCALVES E, Fontes F, Rodrigues JR, Calisto R, et al
    Second primary cancers among females with a first primary cervical, uterine and ovarian cancer: a population-based study in North Portugal.
    Cancer Causes Control. 2026;37:136.
    PubMed    
    Abstract available

  38. ADEFOLALU AO
    Cervical Cancer Screening in Women Living with HIV in South Africa: Addressing Health Disparities Through Integrated Prevention Strategies.
    Int J Womens Health. 2026;18:613391.
    PubMed    
    Abstract available

  39. LUVIAN-MORALES J, Rueda-Escalona AA, Delgadillo-Gonzalez M, Cetina-Perez LDC, et al
    Benefits of an anti-inflammatory diet compared to a low-residue diet during concurrent chemoradiation therapy for patients with locally advanced cervical cancer: a randomized clinical trial.
    Front Nutr. 2026;13:1835417.
    PubMed    
    Abstract available

  40. DOU Z, Yu S, Zhang J, Wu X, et al
    Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study.
    Front Oncol. 2026;16:1826692.
    PubMed    
    Abstract available

  41. WANG W, Li X, Jiang Y, Lu Y, et al
    Non-contrast MRI Radiomics Nomogram for Predicting Recurrence and Progression-Free Survival in Cervical Cancer following Concurrent Chemoradiotherapy.
    Curr Med Imaging. 2026 Jul 23. doi: 10.2174/0115734056449836260717192214.
    PubMed    
    Abstract available

  42. SORBYE SW, Falang BM, Antonsen M, Richardsen E, et al
    Genotype-Specific HPV E6/E7 mRNA Triage for Risk Stratification in HPV DNA-Positive Women with ASC-US/LSIL: A Population-Based Tromso Cohort.
    Pathogens. 2026;15:747.
    PubMed    
    Abstract available

  43. SAYER TG, Yilmaz G, Ozdemir F
    Cisplatin and epsilon-Viniferin Synergistically Modulate Oxidative Stress in HeLa Cells: Implications for Redox Modulation in Cervical Cancer Cells.
    Molecules. 2026;31:2409.
    PubMed    
    Abstract available

  44. CORTES J, Nassar N, Blasco MDR, Castano R, et al
    Rapid Systematic Review-Informed Multidisciplinary Expert Consensus on the Management of HPV-Positive Women with Low-Grade Cervical Lesions and the Role of a Coriolus versicolor-Based Vaginal Treatment.
    Medicina (Kaunas). 2026;62:1283.
    PubMed    
    Abstract available

  45. UCAR M, Yigit MF, Kartal SA, Yagan A, et al
    Effect of a Health Belief Model Based Education Program on Women's Cervical Cancer Knowledge and HPV Vaccination Attitudes in Primary Care Settings.
    Healthcare (Basel). 2026;14:2118.
    PubMed    
    Abstract available

  46. EBNER C, Ebner L, Skvortsov S, Fiegl H, et al
    Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study.
    Cancers (Basel). 2026;18:2225.
    PubMed    
    Abstract available

  47. DRUMOND HC, Silvestrini MMA, Dos Santos LM, Magalhaes-Gama F, et al
    Elevated Circulating Extracellular Vesicles as Prognostic Biomarkers in Cervical Cancer Progression.
    Biomedicines. 2026;14:1492.
    PubMed    
    Abstract available

  48. SANTOS F, Silva MS, Caramelo FA, Santana MM, et al
    Cell-Free DNA Fragmentation Patterns as Biomarkers for Human Papillomavirus-Related Cancers: A Systematic Review of Methodological Diversity and Diagnostic Performance.
    Int J Mol Sci. 2026;27:6372.
    PubMed    
    Abstract available

  49. SUN Q, Wang D, Zhao Q, Cui Y, et al
    PET117 Deficiency Confers Ferroptosis Resistance Through ACSF2 Downregulation in Cervical Cancer.
    Antioxidants (Basel). 2026;15:876.
    PubMed    
    Abstract available

  50. DE MELO NETO AB, Queiroz FR, de Souza Melo CP, Duarte BCD, et al
    ATF4, ZIK1, and PNMA3 Transcriptomic Signatures Predict Chemoradiotherapy Response in Cervical Cancer.
    Cancer Med. 2026;15:e72053.
    PubMed    
    Abstract available

  51. NG XR, Quek IP, Pereira MJ, Molina JA, et al
    Effect of Self-Sampling HPV DNA Testing on Cervical Cancer Screening in Singapore's Primary Care: Pragmatic Randomized Controlled Trial.
    Ann Fam Med. 2026;24:291-300.
    PubMed    
    Abstract available

  52. JOHANSEN ME, Ihongbe TO, McClain M
    Annals Journal Club: HPV Self-Sampling vs Clinician Sampling for Cervical Cancer Screening.
    Ann Fam Med. 2026;24:381.
    PubMed    


  53. KATARIA B, Mukhopadhyay A, Oaknin A, O'Donnell DM, et al
    Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.
    Lancet Oncol. 2026;27:e379-e391.
    PubMed    
    Abstract available

  54. ALCAZAR JL, Espinosa F, de la Maza F, Opazo MP, et al
    Role of three-dimensional ultrasound in the diagnosis and staging of gynecological malignancies: Focus on endometrial and cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2026;108:102758.
    PubMed    
    Abstract available

  55. JIA J, Wang L, Wang F
    Considerations for the Clinical Translation of Low-Dose Computed Tomography-Based Plan-Pool Adaptive Radiotherapy in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;57:104284.
    PubMed    


  56. NAVYA VB, Muraleedharan G, Fasna PK, Kumar R, et al
    A prognostic immune signaling-related lncRNA-circRNA-mRNA network model for cervical cancer using machine learning.
    Biochem Biophys Res Commun. 2026;831:154337.
    PubMed    
    Abstract available

  57. QIAN L, Li Y, Zheng J, Liang T, et al
    GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer.
    Cell Rep. 2026;45:117704.
    PubMed    
    Abstract available

  58. LI Z, Tang L, Wang M, Yu Q, et al
    beta-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells.
    J Biochem Mol Toxicol. 2026;40:e71032.
    PubMed    
    Abstract available

  59. ORTEGA-AGUIRRE MF, Olivas-Armendariz I, Silva-Espinoza JC, Hernandez-Gonzalez ME, et al
    Characterization of Hydrogels of Gelatin/O-Carboxymethyl Chitosan in Ovule Form with Curcumin and Retinyl Palmitate as a Treatment for Cervical Cancer.
    Gels. 2026;12:618.
    PubMed    
    Abstract available

  60. XU T, Ke J, Yue Y, Zhu Z, et al
    The Efficacy of Transcutaneous Electrical Acupoint Stimulation as an Adjunct to Standard Bladder Training for Bladder Emptying After Radical Hysterectomy for Cervical Cancer: A Randomized Controlled Trial.
    Curr Oncol. 2026;33:424.
    PubMed    
    Abstract available

  61. HEWAPATHIRANAGE-MAYADUNNE H, Bergeron E, Kushalnagar P
    Rethinking Communication Barriers: Educational Attainment in Cervical Cancer Screening Among American Sign Language Users.
    Eur J Investig Health Psychol Educ. 2026;16:97.
    PubMed    
    Abstract available

  62. KASE S, Zimmermann ML, Magi M, Baburin A, et al
    Changing burden of cancers related to human papillomavirus in Estonia: a population-based registry study.
    Acta Oncol. 2026;65:632-640.
    PubMed    
    Abstract available

  63. VISHNOI MG, Jain A, Akhariya R, Balaan V, et al
    Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators - a prospective study with paradigm-shifting clinical implications.
    Nucl Med Rev Cent East Eur. 2026;29:e00626007.
    PubMed    
    Abstract available

  64. BARUWA OJ, Singini MG, Gwebu H, Nduka CC, et al
    Accelerating cervical cancer elimination: healthcare decision-making and cervical cancer screening uptake in sub-Saharan Africa.
    Prev Med Rep. 2026;69:103572.
    PubMed    
    Abstract available

  65. ABDUL KARIM SIDDIQUE F, de Zeeuw J, Koot JAR, Nakisige C, et al
    Effectiveness of community-based culturally tailored cervical cancer awareness interventions among women and decision-making men in low-resource settings: A pre-post design evaluation in rural Uganda and Bangladesh.
    Prev Med Rep. 2026;69:103575.
    PubMed    
    Abstract available

  66. CAI Z, Liu D, He Y, Fang Z, et al
    Stichopus japonicus acidic mucopolysaccharide (SJAMP) exerts the tumor-suppressive activity in cervical cancer by targeting TFAP2A to downregulate CENPW.
    Cytotechnology. 2026;78:165.
    PubMed    
    Abstract available

  67. ARIMOTO T, Kasamatsu T, Machida R, Toita T, et al
    A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).
    J Gynecol Oncol. 2026 Jul 13. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  68. YIN X, Tian X, Huang C, Xiang S, et al
    Exploratory preoperative assessment of lymphovascular space invasion in cervical cancer: comparative insights from intravoxel incoherent motion and diffusion-relaxation correlation spectrum imaging.
    Br J Radiol. 2026 Jul 25:tqag169. doi: 10.1093.
    PubMed    
    Abstract available

  69. ARYA K, Tiwari R, Singh V, Sukla P, et al
    Assessment of Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Its Vaccine Among Adolescent Girls at an Urban Health Training Center in Chhallapura, Datia, Madhya Pradesh: A Community-Based Study.
    Cureus. 2026;18:e111412.
    PubMed    
    Abstract available

  70. PENG C, Liang C, Liu J, Liu Y, et al
    Small RNA sequencing identifies tsRNA-05020 as a potential regulator of cervical cancer progression.
    Turk J Biol. 2026;50:197-208.
    PubMed    
    Abstract available


  71. Retraction: miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
    Oncol Res. 2026;34:31.
    PubMed    
    Abstract available

  72. THOBIAS AR, Patel KA, Mehta KA, Patel BM, et al
    Transcriptional Scenario of Altered Glycosylation in HPV-Associated Cervical Cancer.
    Indian J Clin Biochem. 2026;41:598-605.
    PubMed    
    Abstract available

  73. BAHADUR B, Choudhary S, Oswal D, Singh T, et al
    Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India.
    Front Oncol. 2026;16:1872738.
    PubMed    
    Abstract available

  74. LUO Y, Xie XH, Huang XQ, Hu HQ, et al
    A prognostic signature based on methionine metabolism-related genes for cervical cancer: integrated transcriptomic and experimental validation.
    PeerJ. 2026;14:e21538.
    PubMed    
    Abstract available

  75. GRILLO N, Almendra R, Correia C
    Assessment of the impact of nonavalent human papillomavirus vaccine on disease clearance time in women with active infection.
    Rev Bras Ginecol Obstet. 2026;48:e-rbgo17.
    PubMed    
    Abstract available

  76. SINGH K, Grover A, Dhanasekaran K
    Cascade strengthening and test choice are complementary, not competing in Indian cervical cancer screening.
    Glob Epidemiol. 2026;12:100277.
    PubMed    


  77. DOYLE CM, Ronn MM, van Schalkwyk C, Brisson M, et al
    Potential Impact of Catch-Up HPV Vaccination on HPV Prevalence and Cervical Cancer Incidence Among Women Living With HIV in South Africa: Results From Two Mathematical Models.
    J Int AIDS Soc. 2026;29 Suppl 2.
    PubMed    
    Abstract available

  78. PETER O, Oborevwori E, Osagie E, Akhigbe P, et al
    From Awareness to Action Study: Improving Human Papillomavirus Knowledge, Screening and Vaccine Uptake Among Mother-Adolescent Pairs in the HOMINY Study in Nigeria: A Longitudinal Study.
    J Int AIDS Soc. 2026;29 Suppl 2.
    PubMed    
    Abstract available

  79. IKEDA S, Kawaguchi S, Baba K, Takahashi H, et al
    Salvage tacrolimus therapy for steroid-refractory immune-related adverse event-associated sclerosing cholangitis.
    Clin J Gastroenterol. 2026;19:1003-1007.
    PubMed    
    Abstract available

  80. JOPS P, Wolter A, Bavor C, Dodd R, et al
    Qualitative insights into the acceptability of self-collection for cervical screening amongst under- and never-screened groups in Australia.
    BMC Public Health. 2026;26:2242.
    PubMed    
    Abstract available

  81. MONTI E, Monti C, Matozzo CMM, Salmaso M, et al
    The 'see-and-treat' approach in the treatment of preneoplastic cervical lesions.
    Eur J Cancer Prev. 2026;35:465-472.
    PubMed    
    Abstract available

  82. DEJENE K
    Navigating stigma, faith, and fear: understanding HPV vaccine acceptance among adolescent girls in rural parts of Central Ethiopia.
    Cult Health Sex. 2026;28:978-989.
    PubMed    
    Abstract available

  83. ZHU G, Piao Z, Gao Y, Cong X, et al
    Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1alpha-SIX1 axis.
    iScience. 2026;29:117007.
    PubMed    
    Abstract available

  84. SUVVARI TK
    Turning the Tide on Cervical Cancer in India.
    Clin Med Insights Oncol. 2026;20:11795549261471277.
    PubMed    


  85. ZHANG T, Fan W, Liu K, Xu H, et al
    Time-dependent diffusion MRI for assessing tumor microstructure and prognostic risk factors in cervical cancer.
    Abdom Radiol (NY). 2026 Aug 8. doi: 10.1007/s00261-026-05703.
    PubMed    
    Abstract available

  86. KEBEDE FB, Mare KU, Arage FG, Tiyou A, et al
    Predicting lifetime cervical cancer screening among sexually active women in low- and middle-income countries using machine learning models: evidence from Demographic and Health Surveys.
    AJOG Glob Rep. 2026;6:100669.
    PubMed    
    Abstract available

  87. BEJARANO-HERNANDEZ L, Chan A, Gosalia M, Moore M, et al
    Expanding HPV prevention across the life course: evidence on vaccine effectiveness in adults.
    Front Public Health. 2026;14:1894760.
    PubMed    
    Abstract available

  88. GUO Q, Xu C, Li J, Qi C, et al
    COVID-19 vaccination rates as a proxy for health system resilience: implications of development disparities for cervical cancer control during the pandemic.
    Front Med (Lausanne). 2026;13:1858206.
    PubMed    
    Abstract available

  89. HUANG H, Liu L, Cui Y, Zhou F, et al
    Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming.
    Front Immunol. 2026;17:1848357.
    PubMed    
    Abstract available

  90. WANG X, Na J, Wang Y, Han B, et al
    Initial clinical experience with total Mullerian compartment resection for locally advanced cervical cancer: a single-center preliminary retrospective cohort study and learning-curve analysis.
    Front Oncol. 2026;16:1865445.
    PubMed    
    Abstract available

  91. ZHANG J, Chen C, Song H, Li D, et al
    NTMT1 (METTL11A) promotes MYC-dependent proliferation and downstream HLA-A suppression in cervical cancer.
    Front Immunol. 2026;17:1853434.
    PubMed    
    Abstract available

  92. FAUZIA RP, Rahmani AA, Putri RA, Haryuni RD, et al
    Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.
    Sci Rep. 2026;16:24462.
    PubMed    
    Abstract available

  93. ACQUAH-HAGAN G, Boateng D, Boakye K, Idan JS, et al
    Family and sexual functioning among women diagnosed with cervical cancer in Urban Ghana: A mixed-methods study.
    Womens Health (Lond). 2026;22:17455057261476899.
    PubMed    
    Abstract available

  94. TANAKA S, Yamamoto Y, Yokota K, Yamamoto T, et al
    Diagnostic performance of artificial intelligence models trained on scattered single-cell images is not preserved for hyperchromatic crowded cell groups in cervical cytology.
    Cancer Cytopathol. 2026;134:e70140.
    PubMed    
    Abstract available

  95. FENG X, He L, Gao Y, Qiu Y, et al
    Efficacy and safety of a combination of monoclonal antibodies and chemoradiotherapy for the treatment of locally advanced cervical cancer in Chinese patients: a systematic review and meta-analysis.
    Int J Radiat Biol. 2026 Aug 7:1-16. doi: 10.1080/09553002.2026.2710755.
    PubMed    
    Abstract available

  96. LI BY, Fan T, Chen JY, Zhang YH, et al
    Internal feasibility evaluation of SAM-Med3D for cervical cancer clinical target volume segmentation on planning computed tomography.
    Radiol Phys Technol. 2026 Aug 7. doi: 10.1007/s12194-026-01092.
    PubMed    
    Abstract available

  97. LI X, Pan S, Qu P, Wu D, et al
    Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021.
    J Gynecol Oncol. 2026 Jul 31. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  98. YOON HY, Jeon HS, Kim MJ, Kim JM, et al
    Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening.
    J Low Genit Tract Dis. 2026 Aug 7. doi: 10.1097/LGT.0000000000000976.
    PubMed    
    Abstract available

  99. JAISWAL A, Goyal P, Kumari S, Aggarwal D, et al
    Cervical cancer awareness and vaccine hesitancy with respect to HPV vaccination in urban community of Faridabad, Haryana, India.
    Clin Exp Vaccine Res. 2026;15:209-215.
    PubMed    
    Abstract available

  100. ARYANPOUR M, Abolghasemi J, Moghadam SMK
    Psychosocial predictors of cervical cancer screening intention among female teachers in Karaj, Iran: An integrated behavioral model.
    Prev Med Rep. 2026;69:103589.
    PubMed    
    Abstract available

  101. WEI L, Menghui H, Dandan Z, Xin W, et al
    HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products.
    Front Immunol. 2026;17:1892919.
    PubMed    
    Abstract available

  102. PROMTHONG C, Navakanitworakul R, Obaun K, Hanprasertpong J, et al
    Association between Urinary-Extracellular-Vesicle-Enriched Proteome Dynamics and Oncological Outcomes Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer.
    Comput Struct Biotechnol J. 2026;35:0196.
    PubMed    
    Abstract available

  103. HUANG C, Zhang W, Ma X, Li X, et al
    Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling.
    Mol Genet Genomics. 2026;301:165.
    PubMed    
    Abstract available

  104. UCOK BS, Kinay T, Kusabbi IA, Dereli ML, et al
    The association of total oxidant status, total antioxidant status, and ischemia-modified albumin levels with cervical human papillomavirus infection and cervical intraepithelial neoplasia.
    Rev Assoc Med Bras (1992). 2026;72:e20252260.
    PubMed    
    Abstract available

  105. BINTABARA D, Kamata CC, Mohamedi R, Konje E, et al
    Regional variations and predictors of low uptake of cervical cancer screening among women aged 30-49 years in Tanzania: a geospatial and multilevel analysis of population-based survey.
    Res Health Serv Reg. 2026;5:11.
    PubMed    
    Abstract available

  106. KUL KOPRULU T, Erkal Cam B
    Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.
    J Bioenerg Biomembr. 2026;58:45.
    PubMed    
    Abstract available

  107. MA X, Li Y, Yi S, Chen X, et al
    Time-dependent diffusion MRI for differentiating cervical cancer subtypes: impact of ROI delineation strategies on diagnostic performance.
    Abdom Radiol (NY). 2026 Aug 6. doi: 10.1007/s00261-026-05721.
    PubMed    
    Abstract available

  108. KISHIMOTO Y, Sasaki M, Otsuka H, Kubo A, et al
    Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer.
    J Radiat Res. 2026 Aug 6:rrag060. doi: 10.1093.
    PubMed    
    Abstract available

  109. HOU H, Zhang L, Li C, Liu M, et al
    Plasma HPV ctDNA as a dynamic biomarker for treatment response and prognosis in locally advanced cervical cancer: protocol for a prospective cohort study.
    Front Oncol. 2026;16:1844938.
    PubMed    
    Abstract available

  110. LI Z, Duan Z, Liu R, Yu S, et al
    Morphology-defined bacterial vaginosis and HPV-related cervical screening abnormalities: a two-year real-world study with histopathologic correlation.
    Front Cell Infect Microbiol. 2026;16:1890650.
    PubMed    
    Abstract available

  111. QIU L, Li Y, Wang Y, Xie Y, et al
    Higher pre-treatment lymphocyte-to-monocyte ratio predicts better tumor shrinkage after external beam radiotherapy in locally advanced cervical cancer.
    Front Oncol. 2026;16:1917302.
    PubMed    
    Abstract available

  112. RAHAL ADAWI N, Ben Shachar I
    Ethnic Disparity in Cervical Cancer Stage at Diagnosis at a Tertiary Medical Center in Northern Israel: A Retrospective Study.
    Isr Med Assoc J. 2026;28:433-437.
    PubMed    
    Abstract available

  113. SHAH K, Du C, Akgul A, Alshammari FS, et al
    Modelling the impact of awareness campaigns on HPV transmission dynamics: a neural network-enhanced mathematical model.
    Sci Rep. 2026;16:24277.
    PubMed    
    Abstract available

  114. AWAN UA, Zafar N, Khan S
    Infodemic preparedness and the 90-70-90 cervical cancer targets.
    Lancet Digit Health. 2026 Aug 5:101079. doi: 10.1016/j.landig.2026.101079.
    PubMed    


  115. AFTABSAVAD S, Arashkia A, Shokrgozar MA, Rahimi AA, et al
    mRNA vaccines targeting HPV E6/E7: A new frontier in cervical cancer immunotherapy.
    Crit Rev Oncol Hematol. 2026;226:105520.
    PubMed    
    Abstract available

  116. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
    Invasive Cervical Cancer Detection After Transition to Primary Human Papillomavirus Screening: Population-Based Linkage Study in Portugal.
    Acta Med Port. 2026;39:438-447.
    PubMed    
    Abstract available

  117. WATSON JL
    The Cancer That Could Disappear.
    Clin J Oncol Nurs. 2026;30:252-253.
    PubMed    
    Abstract available

  118. QIN H, Yang N, Wang Q, Tian L, et al
    Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.
    Acta Oncol. 2026;65:689-701.
    PubMed    
    Abstract available

  119. RENZAHO AMN, Challam S, Hartcher N, Smith M, et al
    Co-Designing Culturally Tailored Bowel, Cervical and Breast Cancer Screening Interventions With Migrant Communities: Towards Closing the Migration-Related Cancer-Equity Gap in New South Wales, Australia.
    Health Expect. 2026;29:e70805.
    PubMed    
    Abstract available

  120. CHEBAT A, Pharoun J, Rachid M, Bazzi M, et al
    Prevalence and Determinants of Knowledge and Attitudes Toward Cervical Cancer Prevention, Pap Smear Uptake, and Human Papilloma Virus Vaccination Among Lebanese Women.
    Womens Health Rep (New Rochelle). 2026;7:26884844261437618.
    PubMed    
    Abstract available

  121. LOU H, Zhou Y, Li D, Zhang H, et al
    Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
    Cell Rep Med. 2026 Aug 4:102944. doi: 10.1016/j.xcrm.2026.102944.
    PubMed    
    Abstract available

  122. MI J, Guo W, Li L, Wang S, et al
    Single-cell transcriptomics uncovers HPV-driven immune evasion and establishes a TAB2-based prognostic signature in cervical cancer.
    Transl Oncol. 2026;72:102935.
    PubMed    
    Abstract available

  123. JALINK M, King WD, Booth CM, Gien LT, et al
    The diagnosis to surgery interval and overall survival in patients with cervical cancer.
    Cancer Epidemiol. 2026;104:103190.
    PubMed    
    Abstract available

  124. FUKUNAGA C, Hiranuma K, Hirayama T, Yoshida E, et al
    Right Ventricular Metastasis From Cervical Cancer Treated With Pembrolizumab-Containing Chemotherapy: A Case Report and Literature Review.
    Am J Case Rep. 2026;27:e952931.
    PubMed    
    Abstract available

  125. BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
    Correction: Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
    Front Oncol. 2026;16:1929623.
    PubMed    
    Abstract available

  126. CAMPANHA NOVAES LA, Oliveira RD, Tegami IL, Santiago Goncalves MF, et al
    Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.
    iScience. 2026;29:116758.
    PubMed    
    Abstract available

  127. HSIAO KY, Lin HL, Chen CC
    Diagnostic Performance of HPV Testing Using Self-Collected Urine and Vaginal Samples for Detecting Cervical Precancer or Worse: A Meta-Analysis.
    J Obstet Gynaecol Res. 2026;52:e70434.
    PubMed    
    Abstract available

  128. YIGIT E, Gultekin M, Bayatfard P, Yuce Sari S, et al
    The impact of uterine position during brachytherapy on treatment outcomes and toxicity in patients with cervical cancer.
    Strahlenther Onkol. 2026 Aug 3. doi: 10.1007/s00066-026-02582.
    PubMed    
    Abstract available

  129. DONG F, Chen D, Shang JF, Fang W, et al
    [Diagnostic efficacy and teaching value of artificial intelligence-assisted diagnostic systems in cervical liquid-based cytology screening].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:744-751.
    PubMed    
    Abstract available

  130. TEBEJE TM, Metkie KA, Asgedom YS, Gebrekidan AY, et al
    Magnitude of human papillomavirus vaccination uptake and its determinants among adolescent girls in Lesotho: a cross-sectional study.
    BMJ Open. 2026;16:e110615.
    PubMed    
    Abstract available

  131. LYNN T, Sychareun V, Chaleunvong K, Vongxay V, et al
    Integrated service delivery to improve adolescent health and human papillomavirus (HPV) vaccination in Lao PDR: a quasi-experimental mixed-methods study - study protocol.
    BMJ Open. 2026;16:e098836.
    PubMed    
    Abstract available

  132. XIAO Y, Yang L, Yu X, Cheng HJ, et al
    Efficacy and Safety of Camrelizumab Combined with Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Phase II Single-Arm Clinical Trial.
    Clin Oncol (R Coll Radiol). 2026;57:104293.
    PubMed    
    Abstract available

  133. JINDAL R, R R, Ghanghas N, Gupta R, et al
    Addressing HPV vaccine hesitancy and misinformation in India through public health communication strategies.
    Hum Vaccin Immunother. 2026;22:2711551.
    PubMed    
    Abstract available

  134. LIU SQ, Cheng XX, He S, Xia T, et al
    Corrigendum to Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.
    J Clin Invest. 2026;136:e209744.
    PubMed    


  135. LIU L, Du X, Zhao Y, Chen H, et al
    Cost-Related Barriers, Mental Distress, and Cervical Cancer Screening Adherence: A BRFSS 2024 Analysis.
    J Prim Care Community Health. 2026;17:21501319261475712.
    PubMed    
    Abstract available

  136. ADAM J, Mukuku O, Maseb'a Mwang Sulu S, Nsambi JB, et al
    Factors Associated With Cervical Cancer Awareness Among Women of Reproductive Age in the Democratic Republic of the Congo: Evidence From a Nationwide DHS Analysis.
    Cancer Rep (Hoboken). 2026;9:e70633.
    PubMed    
    Abstract available

  137. DOWOU RK, Salu S, Takyiwaa JA, Aboagye RG, et al
    Residency-Based Inequalities in Cervical Cancer Screening in Sub-Saharan Africa.
    Trop Med Int Health. 2026 Aug 2. doi: 10.1111/tmi.70152.
    PubMed    
    Abstract available

  138. SCHLEICHER OM, Dietl AK, Behrens AS, Brueckner L, et al
    Regression of high-grade squamous intraepithelial lesions in women aged 30 years or younger: a retrospective cohort study.
    J Cancer Res Clin Oncol. 2026;152:152.
    PubMed    
    Abstract available

  139. MAEDA M, Kitai M, Akada M, Shimizu Y, et al
    Preoperative prediction of the need for postoperative adjuvant therapy in stage IB cervical cancer using tumor size measured on magnetic resonance imaging and serum squamous cell carcinoma antigen levels.
    AJOG Glob Rep. 2026;6:100671.
    PubMed    
    Abstract available

  140. SOLIMAN S, Thomas T, Barker V, Aboujaoude M, et al
    Association of Increased MIEN1 Copy Number With Worse Outcomes in Lung Adenocarcinoma and Cervical Cancer.
    Cureus. 2026;18:e111880.
    PubMed    
    Abstract available

  141. OLUMODEJI AM, Adefemi AK, Adedeji MO, Edun OQ, et al
    RADICAL HYSTERECTOMY FOR EARLY-STAGE CERVICAL CANCER IN A LOWRESOURCE SETTING: SURGICAL OUTCOMES AND LESSONS FROM A RETROSPECTIVE CROSS-SECTIONAL STUDY.
    Ann Ib Postgrad Med. 2026;24:39-45.
    PubMed    
    Abstract available

  142. CHEN Y, Wang L, Li S, Huang J, et al
    Cross-scale modeling reveals a TFRC-driven immunosuppressive macrophage niche in cervical cancer.
    Front Immunol. 2026;17:1872944.
    PubMed    
    Abstract available

  143. VERGALASOVA I, Jiang C, Song T, Lombe D, et al
    Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration.
    Front Oncol. 2026;16:1872192.
    PubMed    


  144. GONZALEZ GMN, Msadabwe S, Njala B, Sakala D, et al
    Prior Cervical Cancer Screening, Social Determinants of Health, and HIV Status Among Patients at the Cancer Disease Hospital, Zambia.
    Res Sq [Preprint]. 2026 Jul 22:rs.3.rs-10345811.
    PubMed    
    Abstract available

  145. BHAT S, Devi V, Kabekkodu SP
    In silico analysis of driver genes in squamous cell carcinoma of the cervix: insights into their biological functions, prognosis, immune infiltration, and therapy.
    World J Surg Oncol. 2026;24:324.
    PubMed    
    Abstract available

  146. ABUH SO, Barbora A, Nave V, Ben-Arie A, et al
    Attenuated total reflection Fourier transform infrared spectroscopy enables determination of the extent of precancer in cervical conization biopsy.
    Sci Rep. 2026;16:24132.
    PubMed    
    Abstract available

  147. DU M, Wei L, Geng M, Wang W, et al
    Cervical microbial dysbiosis in single HPV16-positive HSIL.
    Sci Rep. 2026;16:23893.
    PubMed    
    Abstract available

  148. MARCADET J, Ayadi S, Mal PA
    When pelvic actinomycosis mimics cervical neoplasia: A diagnostic challenge.
    J Gynecol Obstet Hum Reprod. 2026;55:103222.
    PubMed    
    Abstract available

  149. LI N, Hu Y, van der Zee AGJ, Schuuring E, et al
    PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1411-1420.
    PubMed    
    Abstract available

  150. CHENG J, Yuan H, Su M
    Pleural Metastasis as the Only Presentation of Recurrent Cervical Carcinoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006545.
    PubMed    
    Abstract available

  151. GUONA Z, Yabin S, Qian D, Yang L, et al
    Mixed Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Cervix: A Rare Entity.
    Int J Surg Pathol. 2026;34:1616-1622.
    PubMed    
    Abstract available

  152. BADIGLIAN-FILHO L, Burnett A, Matak L, Ali O, et al
    vNOTES sentinel nodes removal from a remaining cervix.
    J Gynecol Obstet Hum Reprod. 2026;55:103189.
    PubMed    
    Abstract available

  153. DE CAMPOS MR, Carvalho LHSB, Campos AJR, Cora GR, et al
    Knowledge and Perception of Human Papillomavirus in Quilombola Communities in Northeast Brazil.
    Hisp Health Care Int. 2026;24:172-180.
    PubMed    
    Abstract available

  154. OZEN S
    Letter to "Human Papillomavirus (HPV) Awareness, HPV-Related Concern, and Fear of Cancer as Predictors of Attitudes Toward Cervical Cancer Prevention in Women".
    J Obstet Gynaecol Res. 2026;52:e70465.
    PubMed    


  155. URQUHART-DUCHARME R, Dias E, Leonard R, Lu N, et al
    Eliminating cervical cancer in Canada is within reach.
    Can J Public Health. 2026 Aug 14. doi: 10.17269/s41997-026-01240.
    PubMed    
    Abstract available

  156. ALMSAFI T, Ribeiro R, Gilbert L, Leung SOA, et al
    Late metastatic recurrence of stage IA1 cervical cancer 12 years after minimally invasive radical hysterectomy.
    J Minim Invasive Gynecol. 2026 Aug 14:S1553-4650(26)00440.
    PubMed    


  157. CARNEIRO FP, da Silva Rios Chen S, de Araujo Oliveira Nakashoji I, Amancio FFC, et al
    Impact of HPV vaccination on cervical precancer and invasive cervical cancer twelve years after vaccine introduction in the Brazilian Public Health System.
    J Infect Public Health. 2026;19:103326.
    PubMed    
    Abstract available

  158. RAQUE TL, Pointer O, Creegan M, Moody S, et al
    "Don't settle": Rural cervical cancer survivors' navigation of cancer care from an intersectional framework.
    Womens Health (Lond). 2026;22:17455057261478351.
    PubMed    
    Abstract available

  159. TAVARES MV, Felix MM, Batista de Carvalho AL, Santos IP, et al
    Raman microspectroscopy for cervical cancer diagnosis: an ex-vivo cryopreserved tissue analysis.
    Am J Cancer Res. 2026;16:2873-2884.
    PubMed    
    Abstract available

  160. JIN X, Zhang Q, Ling X, Liu Y, et al
    Actin-related protein 2/3 complex subunit 1B promotes cervical cancer cell tumorigenesis in vitro and in vivo.
    Am J Cancer Res. 2026;16:2955-2970.
    PubMed    
    Abstract available

  161. ZHU X, Zhou L, Li R, Shen Q, et al
    Expression of Concern: AGER promotes proliferation and migration in cervical cancer.
    Biosci Rep. 2026;46:BSR20171329.
    PubMed    


  162. HE S, Yu G, Peng K, Liu S, et al
    [Expression of Concern] MicroRNA?145?5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells.
    Mol Med Rep. 2026;34:277.
    PubMed    
    Abstract available

  163. KHALED RK, Abd-Rabou AA, Dawy M, Wahba MA, et al
    Folic acid-loaded amino-functionalized MCM-41 as a drug delivery system for cervical cancer modulating apoptotic and survival signals.
    Sci Rep. 2026;16:25288.
    PubMed    
    Abstract available

  164. LI T, Shi Y, Xu HJ, Zhang YB, et al
    [Prevalence of cervical human papillomavirus infection among women in Honghe Hani and Yi Autonomous Prefecture, Yunnan Province, China].
    Zhonghua Zhong Liu Za Zhi. 2026;48:943-953.
    PubMed    
    Abstract available

  165. ALLICOCK MA, Costa C, McKenzie AH, Loomba P, et al
    Formative Work to Guide Implementation of an Evidence-Based Breast and Cervical Cancer Prevention and Early Detection Behavioral Health Program in Clinics: Qualitative Study Guided by the Consolidated Framework for Implementation Research.
    JMIR Form Res. 2026;10:e89393.
    PubMed    
    Abstract available

  166. STRELOW BA, Byom E, Wangen H, Backlund J, et al
    Text Messaging as a Tool to Address Language Barriers in Cervical Cancer Screening Among Spanish-Preferred Populations: A Quality Improvement Study.
    Cancer Control. 2026;33:10732748261478959.
    PubMed    
    Abstract available

  167. SHASTRI S, Shastri S
    Cancer Screening in India: Lessons, Limitations, and Pragmatic Solutions for the Next Decade.
    JCO Glob Oncol. 2026;12:e2600018.
    PubMed    
    Abstract available

  168. ZHOU J, Liu F, Gao T, Yang Y, et al
    GATA1 knockdown enhances CD8(+) T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.
    J Mol Histol. 2026;57:269.
    PubMed    
    Abstract available

  169. DERVISEFENDIC PELJTO M, Jahic M
    Local carboxymethyl-beta-glucan and polycarbophil therapy is associated with regression of low-grade cervical cytological abnormalities: a prospective observational study.
    Med Glas (Zenica). 2026;23.
    PubMed    
    Abstract available

  170. NIEBERLE LS, Dietl AK, Seibold A, Bruckner L, et al
    Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment.
    Geburtshilfe Frauenheilkd. 2026;86:766-776.
    PubMed    
    Abstract available

  171. PORTILLA V, Mahaluf Recasens F, Bahamonde L
    Reconstruction Using Conventional Implants in a Patient With an Acetabular Fracture Due to Cervical Cancer Metastasis: A Case Report.
    Cureus. 2026;18:e112600.
    PubMed    
    Abstract available

  172. GIRBOVAN AH, Balan C, Kirsch-Mangu AT, Fischer-Fodor E, et al
    Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review.
    Int J Mol Sci. 2026;27:7033.
    PubMed    
    Abstract available

  173. HUANG M, Li S
    Basic Clinical Bidirectional Empowerment: Synergistic Breakthrough in Molecular Mechanisms and Clinical Management of Small Cell Cervical Carcinoma.
    Int J Mol Sci. 2026;27:6783.
    PubMed    
    Abstract available

  174. TOENNIESSEN-KLEIN SM, Rangno D, Sunil A, Bozko M, et al
    Proteomic Analysis of TCGA Data Reveals Limited Prognostic Value of p53 but Suggests BAX as a Potential Survival Marker in Cervical Carcinoma.
    Int J Mol Sci. 2026;27:6717.
    PubMed    
    Abstract available

  175. ZENG Z, Chen Y, Meng X, Sun Y, et al
    Moderately Hypofractionated Online Adaptive Radiotherapy for Cervical Cancer: A Prospective Study of Feasibility, Acute Toxicity and Dosimetric Benefits.
    Cancers (Basel). 2026;18:2493.
    PubMed    
    Abstract available

  176. CAO Y, Wickramage IS, Li C, Tan Y, et al
    Image-Guided Adaptive Brachytherapy Using Patient-Specific 3D-Printed Templates for Complex Locally Advanced Cervical Cancer: A Real-World Implementation Study.
    Cancers (Basel). 2026;18:2399.
    PubMed    
    Abstract available

  177. WATASHIGE N, Kubo-Kaneda M, Makino M, Kato M, et al
    Microbiota-Derived Corisin Is Elevated in Early Cervical Neoplasia and Drives Pathogenic Cellular Programs.
    Cells. 2026;15:1358.
    PubMed    
    Abstract available

  178. KABUKYE JK, Koot JAR, Beltman JJ, Nakatumba-Nabende J, et al
    Frugal AI is the missing piece in cervical cancer screening.
    Nat Med. 2026 Aug 12. doi: 10.1038/s41591-026-04568.
    PubMed    


  179. QIU J, Xu J, Zhang J, He H, et al
    Retraction notice to "Exploring the mechanism by which BXSD decoction treats cervical cancer through the combination of network pharmacology and molecular docking analysis: Molecular mechanism of AKT1 and CASP3 protein" [Int. J. Biol. Macromol. 317 (2
    Int J Biol Macromol. 2026 Aug 12:153987. doi: 10.1016/j.ijbiomac.2026.153987.
    PubMed    


  180. BERNARD C, Thomassin-Naggara I, Campagni L, Carcopino X, et al
    Initial staging workup in cervical cancer: clinical examination, imaging, and laboratory assessment - a review from the french cervical cancer guidelines group.
    J Gynecol Obstet Hum Reprod. 2026 Aug 12:103255.
    PubMed    
    Abstract available

  181. DEMIRDAG B, Ayhan RM, Keles MN, Ogec H, et al
    Effect of human papillomavirus education on human papillomavirus knowledge and gynecologic cancer awareness among women aged 18-49: a randomized controlled study.
    Rev Assoc Med Bras (1992). 2026;72:e20260313.
    PubMed    
    Abstract available

  182. JOMAR RT, Alves LA, Meira KC
    Sexual orientation and time since last Papanicolaou test in Brazil: the 2019 National Health Survey.
    Cien Saude Colet. 2026;31:e16622024.
    PubMed    
    Abstract available

  183. KAMAL S, Qin C, Wang Y, He R, et al
    Exploring the molecular basis of Panax notoginseng mediated inhibition of cervical cancer through machine learning, transcriptomics analysis, network pharmacology, molecular docking, and in-silico simulation approaches.
    Bioinform Adv. 2026;6:vbag164.
    PubMed    
    Abstract available

  184. DANAN ER, Woodward-Abel AB, Gowdy-Jaehnig A, Friedman JK, et al
    Co-production of a conversation guide for HPV-based cervical cancer screening results communication.
    Patient Educ Couns. 2026;152:109809.
    PubMed    
    Abstract available

  185. TAN B, Lin S, Wei X, Chen S, et al
    Clinical Efficacy and Safety of Pembrolizumab-Based Therapy in Recurrent or Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
    Onco Targets Ther. 2026;19:612659.
    PubMed    
    Abstract available

  186. DE ARAUJO RESENDE LS, Conceicao MS, Jales RM, Pereira PN, et al
    Pretreatment CT-defined sarcopenia is associated with worse survival in cervical cancer.
    Gynecol Oncol Rep. 2026;66:102174.
    PubMed    
    Abstract available

  187. SAMARANAYAKE S, Thiruthaneeswaran N, Turner S, Vinod S, et al
    Benchmarking Cervical Cancer Care Pathways-Measuring Timelines and Identifying Factors Associated With Delay for Women Undergoing Definitive Radiotherapy in New South Wales, Australia.
    Aust N Z J Obstet Gynaecol. 2026;66:e70174.
    PubMed    
    Abstract available

  188. DANTAS NMM, Graca A, Soares LC
    Conization With Lymph Node Assessment in Early-Stage Cervical Cancer: A Systematic Review and Meta-Analysis.
    J Obstet Gynaecol Res. 2026;52:e70411.
    PubMed    
    Abstract available

  189. KUSUMA F, Glenardi G, Winarto H, Nuranna L, et al
    Effectiveness of different educational interventions on knowledge, attitude and willingness to undergo cervical cancer screening in rural Indonesia: a quasi-experimental study.
    BMJ Open. 2026;16:e103814.
    PubMed    
    Abstract available

  190. INTURRISI F, Yuma S, Mchome B, Mremi A, et al
    Challenging the assumption that experience- and training-related factors improve accuracy of cervical cancer screening image interpretation: Evidence from Tanzania.
    PLOS Glob Public Health. 2026;6:e0007074.
    PubMed    
    Abstract available

  191. LIU C, Liu Z, Dong C, Jiang X, et al
    USP1 Promotes Malignant Progression of Cervical Cancer Cells by Deubiquitinating and Stabilizing ATG13 to Enhance Autophagic Activity.
    J Biochem Mol Toxicol. 2026;40:e71060.
    PubMed    
    Abstract available

  192. SENIAN AA, Noni V, Jerip AR, Bong ACS, et al
    Evaluation of Sample Pooling Strategies for Point-of-Care HPV DNA Testing Using the STANDARD M10 Platform.
    J Med Virol. 2026;98:e71101.
    PubMed    
    Abstract available

  193. WANG X, Song F, Lin Y, Wu A, et al
    Nutritional Support Needs of Cervical Cancer Patients Undergoing Chemoradiotherapy: A Qualitative Study.
    Int J Womens Health. 2026;18:609685.
    PubMed    
    Abstract available

  194. TAKEMURA H, Taki M, Okamoto H, Ikeda A, et al
    Reproductive and Perinatal Outcomes After Trachelectomy: Vaginal Microbiota and Early Preterm Birth.
    J Obstet Gynaecol Res. 2026;52:e70437.
    PubMed    
    Abstract available

  195. SUGITA C, Nakamura Y, Yoshimoto Y, Fujiwara S, et al
    [Cervical cancer metastasis to the lumbosacral spinal root: a case report].
    Rinsho Shinkeigaku. 2026 Aug 7. doi: 10.5692/clinicalneurol.cn-002272.
    PubMed    
    Abstract available

  196. ALESHIRE M, Huffines R, Tinman JS, Croghan A, et al
    Acceptability of At-Home hrHPV Cervical Cancer Screening For Transmasculine Individuals: A Qualitative Descriptive Study.
    West J Nurs Res. 2026 Aug 9:1939459261464522. doi: 10.1177/01939459261464522.
    PubMed    
    Abstract available

  197. DE RIDDER LA, Zusterzeel PLM, Kruse AJ
    Clinician-perceived clinical accuracy and guideline alignment of ChatGPT responses to patient questions on HPV and CIN: a two-year comparative evaluation.
    Int J Med Inform. 2026;220:106636.
    PubMed    
    Abstract available

  198. GYAMFI-SAMAKOME A, Nimo FA, Odoom E, Nabe B, et al
    Impact of health education intervention on knowledge and attitude towards HPV vaccination in Africa: A systematic review.
    Vaccine. 2026;88:128930.
    PubMed    
    Abstract available

  199. CHEN J, Li J, Wu J, Li Y, et al
    The Impact of Surgery and Survival Prediction on Patients with Locally Advanced Gastric-type Endocervical Adenocarcinoma: A Population-Based Cohort Study.
    Ann Surg Oncol. 2026;33:8369-8379.
    PubMed    
    Abstract available

  200. JIA Q, Liu J, Xu T, Zhao P, et al
    COL6A3 drives tumor progression and predicts prognosis in cervical squamous cell carcinoma.
    Pathol Res Pract. 2026;286:156612.
    PubMed    
    Abstract available

  201. UNER FO, Korukcu O
    Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.
    Semin Oncol Nurs. 2026;42:152284.
    PubMed    
    Abstract available

  202. YANG H, Gao X, Zhang R, Pei C, et al
    Personal vs professional HPV vaccination and screening among female healthcare workers in China.
    Vaccine. 2026;88:128879.
    PubMed    
    Abstract available

  203. ALAMGIR M, Randimbivololona J, Patelisio PN, Tukia O, et al
    Behavioural and social drivers of HPV vaccine uptake in Tonga: a mixed-methods study using the WHO BeSD framework and Talanoa in a Pacific Island setting.
    Vaccine. 2026;88:128843.
    PubMed    
    Abstract available

  204. OSEI-NTIAMOAH B, Apau-Danso PKA, Iddrisu M, Osae-Larbi J, et al
    Prevalence of cervical human papillomavirus infection among women in Ghana: a systematic review and meta-analysis.
    BMC Public Health. 2026;26:2325.
    PubMed    
    Abstract available

  205. ZHANG W, Li D, Liu S, Tang J, et al
    CFD overexpression inhibits CESC progression and enhances TIL therapy efficacy via NOSTRIN and eNOS signaling pathway.
    Sci Rep. 2026;16:25173.
    PubMed    
    Abstract available

  206. ALZAYADNEH E, Dibbern ME, Rabban J, Fadare O, et al
    HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in the Gynecologic Tract.
    Int J Gynecol Pathol. 2026;45:349-357.
    PubMed    
    Abstract available

  207. SALAZAR-HUAYNA L, Acosta U, Centeno Mediavilla MC, Serra M, et al
    HPV Methylation as a Marker of Progression to High-Grade Squamous Intraepithelial Lesions (HSIL) in Patients With Negative Cytology/ASCUS and High-Risk HPV Positive.
    Int J Gynecol Pathol. 2026;45:377-382.
    PubMed    
    Abstract available

  208. NIIYAMA T, Kido A, Kawabe H, Himoto Y, et al
    Progressive MRI changes in lobular endocervical glandular hyperplasia suggesting malignant transformation: report of two cases with histopathologic correlation.
    Abdom Radiol (NY). 2026;51:4544-4550.
    PubMed    
    Abstract available

  209. KUBAI WK, Odongo AO, Rithaa GK
    Awareness, knowledge, and cervical cancer screening behaviour in an urban informal settlement: Evidence from multinomial and interaction models.
    PLOS Glob Public Health. 2026;6:e0007013.
    PubMed    
    Abstract available

  210. LI Y, Wang Y, Kang Y, Luo F, et al
    A Multimodal Graph Neural Network Based on MRI Radi-omics for Prognostic Prediction in Locally Advanced Cervical Squamous Cell Carcinoma.
    Cancer Control. 2026;33:10732748261480328.
    PubMed    
    Abstract available

  211. ZONDI S, Mogale M, Khalongo E
    Knowledge of cervical cancer screening, barriers to awareness, and the role of technological interventions in improving screening uptake: a scoping review protocol.
    Front Health Serv. 2026;6:1857077.
    PubMed    
    Abstract available

  212. LIU W, Yin H, Wang B, Li Z, et al
    Restriction spectrum imaging and diffusion kurtosis imaging for evaluating proliferation status in cervical cancer.
    Front Med (Lausanne). 2026;13:1855242.
    PubMed    
    Abstract available

  213. ABICH K, Masrour R, Akouibaa A, Benhamou M, et al
    Numerical study of the optimization of theranostic performance of (Au/SiO(2)/Au) spherical gold nanomatryoshkas for cervical cancer through structural tuning: Comparative analysis in healthy and infected tissues.
    Nanomedicine. 2026 Aug 20:103010. doi: 10.1016/j.nano.2026.103010.
    PubMed    
    Abstract available

  214. YAN T, Muhebuli M, Ablise M, Mulati S, et al
    Discovery of novel Quinazoline-chalcone hybrids as dual VEGFR-2/P-gp inhibitors to reverse cisplatin resistance in cervical Cancer.
    Bioorg Chem. 2026;181:110411.
    PubMed    
    Abstract available

  215. FREY M, Lapp L, Swander L, Zhang RC, et al
    Persistent Racial, Ethnic, and County-Level Disparities in Invasive Cervical Cancer Incidence in Wisconsin, 1998-2022.
    WMJ. 2026;125:383-387.
    PubMed    
    Abstract available

  216. ZHANG Y, Abuduwufu S, Zhuo Q, Zhang J, et al
    Transcription Factor ELF3 Promotes Cervical Cancer Progression via Transcriptional Upregulation of GMPS.
    Mol Carcinog. 2026 Aug 20. doi: 10.1002/mc.70167.
    PubMed    
    Abstract available

  217. ZHAO Y, Wang N, Ma C, Tian S, et al
    Intravoxel incoherent motion imaging with improved image quality by deep learning reconstruction for prediction of lymph-vascular space invasion in patients with cervical cancer.
    Abdom Radiol (NY). 2026 Aug 20. doi: 10.1007/s00261-026-05725.
    PubMed    
    Abstract available

  218. DAWUTI R, Yao L, Wutikuer M, Liu X, et al
    Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.
    Am J Clin Oncol. 2026 Aug 24. doi: 10.1097/COC.0000000000001364.
    PubMed    
    Abstract available

  219. JONES TE, Matsko J, Wu D, Zeng X, et al
    Assessment of atypical glandular cell interpretation in Pap tests using the Hologic Genius Digital Diagnostics System.
    Cancer Cytopathol. 2026;134:e70148.
    PubMed    
    Abstract available

  220. WU YL, Ho CW, Liou WS, Yin CH, et al
    The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice.
    Kaohsiung J Med Sci. 2026 Aug 20:e70272. doi: 10.1002/kjm2.70272.
    PubMed    
    Abstract available

  221. HE Y, Zhao Y, Ju S, Zhou P, et al
    The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance.
    Front Cell Infect Microbiol. 2026;16:1890330.
    PubMed    
    Abstract available

  222. DOE Y, Aboelata N, Alvarez-Nutting M, Golden D, et al
    Improving Cervical Cancer Screening Participation Through Human Papillomavirus Self-Sampling: A Scoping Review of Evidence in Underserved Populations.
    Womens Health Rep (New Rochelle). 2026;7:26884844261469765.
    PubMed    
    Abstract available

  223. ICHIDA K, Yamamoto K, Suzuki Y, Mitsuoka M, et al
    Real-world efficacy and safety of cemiplimab in Japanese patients with recurrent or metastatic cervical cancer: A single-center retrospective cohort study.
    Gynecol Oncol Rep. 2026;66:102185.
    PubMed    
    Abstract available

  224. KONG X, Zhang B, Zhang G, Xiao H, et al
    Platform-specific comparison of IMRT and VMAT angular resolution for Ethos-based online adaptive radiotherapy in cervical cancer.
    Front Oncol. 2026;16:1888330.
    PubMed    
    Abstract available

  225. STEINKASSERER L, Wilhelm LM, Schambach J, Schaffler H, et al
    Analysis of the temporal changes in management of early-stage cervical cancer over a 10-year period in Germany: a multicenter retrospective analysis of the JAGO/NOGGO.
    Front Oncol. 2026;16:1916573.
    PubMed    
    Abstract available


  226. RETRACTION: MicroRNA-374b Inhibits Cervical Cancer Cell Proliferation and Induces Apoptosis Through the p38/ERK Signaling Pathway by Binding to JAM-2.
    J Cell Physiol. 2026;241:e70217.
    PubMed    


  227. NUMMINEN E, Louvanto K
    Host Characteristics and Genotype-Specific Risks of Human Papillomavirus in Cervical Cancer Screening (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2026 Aug 19:S0002-9378(26)00423.
    PubMed    


  228. SINHA N
    Digital health information: Validity and reliability check of Hindi YouTube videos on cervical cancer.
    Indian J Cancer. 2026 Aug 18. doi: 10.4103.
    PubMed    
    Abstract available

  229. SUZUKI T, Yoshikawa N, Kamiya C, Katayama K, et al
    Post-CCRT pelvic lymph node size and pathological nodal involvement in cervical cancer.
    Int J Clin Oncol. 2026 Aug 19. doi: 10.1007/s10147-026-03174.
    PubMed    
    Abstract available

  230. HO HTT, Phan TT, Nguyen KT, Nguyen HH, et al
    Agreement Between the CerviCARE AI Artificial-Intelligence Software and Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Women Aged Over 18 Years in Vinh Long Province, Vietnam: A Community-Based Cross-Sectional Study.
    Int J Womens Health. 2026;18:637592.
    PubMed    
    Abstract available

  231. LU M, Fan Y, Guo S, Yao L, et al
    Circ_0070190 suppresses the malignant progression of cervical cancer by sponging miR-587.
    J Mol Histol. 2026;57:277.
    PubMed    
    Abstract available

  232. ELDIEN A, Hankins L, Neilson T, Jacobson I, et al
    Rural-Urban Differences in Cervical Cancer Screening Patterns: A Cross-Sectional Analysis of the 2021 National Health Interview Survey (NHIS).
    J Rural Health. 2026;42:e70210.
    PubMed    
    Abstract available

  233. YANG MQ, Huang P, Song YR, Wu YZ, et al
    Exosomal hnRNPA1-delivered miR-27a-3p inhibits the radiation-induced bystander effect in cervical cancer.
    Precis Radiat Oncol. 2026 Aug 17:10.1002/pro6.70084. doi: 10.1002/pro6.70084.
    PubMed    
    Abstract available

  234. DEHGHANI T, Hosseini SM, Dorazehi J, Nazari SE, et al
    In vivo assessment of imoxide and diluted vitamin C's inhibitory effects on cervical cancer in mice.
    Iran J Basic Med Sci. 2026;29:971-978.
    PubMed    
    Abstract available

  235. LIU H, Zhang Z, Xu J, Li J, et al
    Commentary: Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.
    Front Immunol. 2026;17:1902016.
    PubMed    


  236. IBRAHIM FM, Ibrahim AM, Dabou EAR, Elhameed SA, et al
    HPV prevention awareness, vaccination willingness, and vaccine-related perceptions among middle-school girls in three Arab countries: an exploratory online survey.
    Front Public Health. 2026;14:1902409.
    PubMed    
    Abstract available

  237. KOU H, Li Q, Hu X, Yue K, et al
    Changes in Depressive Symptoms Following Mindfulness Training in Female Patients With Abdominal or Abdominopelvic Cancer: A Preliminary Non-Randomized Controlled Study.
    Psychooncology. 2026;35:e70585.
    PubMed    
    Abstract available

  238. ZHAO G, Xu J, Liu G, Li S, et al
    Construction and Validation of a Risk Prediction Model for Lower Limb Lymphedema After Cervical Cancer Surgery: A Prospective Cohort Study.
    Cancer Med. 2026;15:e72194.
    PubMed    
    Abstract available

  239. KITA M, Butsuhara Y, Mizokami T, Murata H, et al
    Endoscopy-assisted precise radical hysterectomy and perioperative chemotherapy for locally advanced cervical cancer: feasibility and clinical outcomes compared with radiotherapy.
    Jpn J Clin Oncol. 2026 Aug 18:hyag132. doi: 10.1093.
    PubMed    
    Abstract available

  240. GAIDHANE AS, Malvika AM, Vasava M, Kevlani V, et al
    Network pharmacology, molecular docking, and dynamics simulation reveal multi-target mechanisms of Mesua ferrea linn phytochemicals against cervical cancer.
    Comput Biol Chem. 2026;125:109322.
    PubMed    
    Abstract available

  241. LEINO A, Numminen E, Fonagy V, Paloniemi M, et al
    Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.
    Eur J Public Health. 2026;36:ckag139.
    PubMed    
    Abstract available

  242. WANG Q, Xu W, Feng L, Ling P, et al
    Regulating the activity of cervical cancer cells through electrochemical modulation of membrane-surface redox states.
    Chem Commun (Camb). 2026 Aug 17. doi: 10.1039/d6cc04339.
    PubMed    
    Abstract available

  243. DHILLON SK, Latsuzbaia A, Vandenbroeck D, Pretet JL, et al
    Clinical Validation of the Sansure Human Papillomavirus DNA Diagnostic Kit for Use in Primary Cervical Cancer Screening.
    J Med Virol. 2026;98:e71106.
    PubMed    
    Abstract available

  244. CUELLAR S, Lay L, Silva MRD, Martinez NS, et al
    [Electrochemotherapy for the treatment of perianal carcinoma concomitant with cervical carcinoma].
    Medicina (B Aires). 2026;86:1067-1071.
    PubMed    
    Abstract available

  245. PILCO J, Cabezas C, Samaniego L, Sinchiguano G, et al
    A COMPARATIVE ANALYSIS OF TRENDS IN CERVICAL CANCER MORTALITY AMONG MESTIZO AND INDIGENOUS WOMEN IN ECUADOR, 2010-2024.
    Georgian Med News. 2026;:90-95.
    PubMed    
    Abstract available

  246. FERNANDEZ-DEAZA G, Ortiz N, Salazar A, Parra A, et al
    Participation and Follow-Up Compliance in Cervical Cancer Screening According to Delivery Strategy for HPV Self-Collection: A Community Trial in Underserved Colombian Areas.
    Cancer Med. 2026;15:e72171.
    PubMed    
    Abstract available

  247. STEINBERG B, Paul R, Copeland M, Herrick C, et al
    Cervical Cancer Screening Preferences in Transgender, Nonbinary, and Gender-diverse Patients.
    O G Open. 2026;3:e196.
    PubMed    
    Abstract available

  248. SUN Y, Zhang J, Guo L, Zhang J, et al
    BUB1 regulates cell proliferation and apoptosis in cervical cancer by AKT signaling and autophagosome-lysosome fusion via ACTN1.
    iScience. 2026;29:117040.
    PubMed    
    Abstract available

  249. ZUNDONG Y, Xiaoxue L, Rodewald L, Fuzhen W, et al
    Entering into life-course immunization: Process, significance, and prospects of HPV vaccine inclusion into the national immunization program of China.
    Vaccine. 2026;89:129000.
    PubMed    
    Abstract available

  250. PALANDE V, Zhang T, Smith KN, Levinson K, et al
    Exploration of immune correlates of viral clearance after PVX2 immunotherapy in patients with human papillomavirus type 16 infection and cervical intraepithelial neoplasia grade
    J Virol. 2026;100:e0064326.
    PubMed    
    Abstract available

  251. SPURGEON ME
    The cervicovaginal microbiome: an emerging determinant of HPV infection and disease.
    J Virol. 2026 Jul 23:e0170625. doi: 10.1128/jvi.01706.
    PubMed    
    Abstract available

  252. TRAN PL, Hcini N, Chevallier L, Vieille P, et al
    [Specificity in the management of gynecological cancers in French overseas departments].
    Bull Cancer. 2026;113:1025-1037.
    PubMed    
    Abstract available

  253. JUNEJA S, Bhati BS
    MedFusionNet: A hybrid transformer-based multimodal deep learning framework for chronic disease prediction in women's health.
    Comput Med Imaging Graph. 2026;134:102795.
    PubMed    
    Abstract available

  254. CHEN W, Gu X, Cai L, Tang J, et al
    Ultrasensitive detection of HPV-associated lower genital tract lesions using a NIR-excited luminescent assay with lanthanide-doped upconversion nanoprobes and enzymatic digestion protection.
    Talanta. 2026;310:130139.
    PubMed    
    Abstract available

  255. DIELEMAN M, Vermeulen KM, Siebers AG, Wisman BA, et al
    Young women with (pre)malignant cervical disease in northern Netherlands: what characterises them - A population-based cohort study.
    BMC Womens Health. 2026;26:404.
    PubMed    
    Abstract available

  256. LE BONNIEC A, Woods S, McGlacken T, O'Connor M, et al
    What are the views and experiences of human papillomavirus (HPV) self-sampling for cervical screening in high-income countries? A qualitative systematic review using the Theoretical Domains Framework.
    BMC Public Health. 2026;26:2382.
    PubMed    
    Abstract available

  257. WEI X, Huang X, Huang Y, Yang X, et al
    Co-detection of human papillomavirus and human herpesvirus in women from Yunnan, China: associations with cervical lesion severity.
    BMC Infect Dis. 2026;26:1499.
    PubMed    
    Abstract available

  258. DUTTA M, Manguri C, Lalrothuama, Taye M, et al
    Promoter methylation of APC, P16, and WT1 genes among high-risk HPV infected women of North-Eastern states of India.
    Indian J Med Microbiol. 2026;62:101118.
    PubMed    
    Abstract available

  259. BROND M, Christensen T, Randrup TH, Tarpo CL, et al
    The role of misclassification in progression of cervical intraepithelial neoplasia grade 2 during active surveillance: results from a historical cohort.
    Am J Obstet Gynecol. 2026;235:584-593.
    PubMed    
    Abstract available

  260. HAM A, Harakeh Z, Kasmi S, Gidaly D, et al
    Enhancing Participation in Population Based Cancer Screening: Culturally Sensitive Approaches for Underserved Women.
    J Transcult Nurs. 2026;37:748-755.
    PubMed    
    Abstract available

  261. BONVICINI L, Iorio G, Ghirotto L, Auzzi N, et al
    The co-creation of a document to guide the use of self-sampling for human papillomavirus screening in Italy.
    J Med Screen. 2026;33:163-171.
    PubMed    
    Abstract available

  262. CULLIMORE VA, Dean T, Chu K, Brentnall A, et al
    Comparison of Cervical Screening at 6- and 12-Weeks Postnatal: A Paired-Sample Feasibility Study.
    BJOG. 2026;133:1857-1865.
    PubMed    
    Abstract available

  263. QI J, Nie G
    Human papillomavirus 42: from a low-risk genotype to a potentially oncogenic virus.
    Clin Exp Dermatol. 2026;51:1604-1610.
    PubMed    
    Abstract available

  264. KEMP E, Sim J, Chew-Graham CA, Finney AG, et al
    Acceptability of, and preference for, human papillomavirus self-sampling for physically Disabled women: A cross-sectional survey.
    J Med Screen. 2026;33:172-179.
    PubMed    
    Abstract available

  265. OZTURK KELES F, Korkmaz I, Dogan E, Hakverdi S, et al
    Our clinical experience in pelvic magnetic resonance imaging with vaginal contrast.
    Ginekol Pol. 2023;94:198-202.
    PubMed    
    Abstract available

  266. HEALSMITH S, Foster L, Chard J, Brand A, et al
    Cisplatin-induced sarcoidosis-like reaction after primary chemoradiotherapy for locally advanced cervical cancer.
    BMJ Case Rep. 2026;19:e271654.
    PubMed    
    Abstract available

  267. SINGH P, Bhushan B, Kumar A, Misra G, et al
    Integrating non-coding RNA profiling with HPV genotyping for cervical cancer risk stratification and early detection.
    Mol Biol Rep. 2026;53:1482.
    PubMed    
    Abstract available

  268. GROSS S, Dalphin L, Dor F, Ramanah R, et al
    Frequent detection of high-risk HPV types other than HPV 16/18 in a cohort of French women who claimed to have been vaccinated.
    Arch Virol. 2026;171:262.
    PubMed    
    Abstract available

  269. ZHANG T, Fan W, Liu K, Xu H, et al
    Correction: Time-dependent diffusion MRI for assessing tumor microstructure and prognostic risk factors in cervical cancer.
    Abdom Radiol (NY). 2026 Aug 17. doi: 10.1007/s00261-026-05757.
    PubMed    


  270. PITAKKARNKUL S, Khomphaiboonkij U, Tangjitgamol S, Srisomboon J, et al
    Knowledge, Attitude, and Clinical Practice of HPV Vaccination and Cervical Cancer Screening: A National Survey of OB-GYN Practitioners in Thailand.
    Asian Pac J Cancer Prev. 2026;27:3097-3103.
    PubMed    
    Abstract available

  271. SAHOO SS, Kumar P, Kumar R, Ludhiadch A, et al
    Content Quality of YouTube Videos on Human Papillomavirus Vaccine: A Systematic Analysis.
    Asian Pac J Cancer Prev. 2026;27:3029-3036.
    PubMed    
    Abstract available

  272. MUCHTARIZA S, Masnarivan Y, Ilmaskal R
    Predictors of Cervical Cancer Screening Uptake Among Women of Reproductive Age in Indonesia: A Nationwide Cross-Sectional Study Based on the 2023 Indonesian Health Survey.
    Asian Pac J Cancer Prev. 2026;27:3013-3020.
    PubMed    
    Abstract available

  273. ARMERINAYANTI NW, Lestari DPO, Wiguna IGWW
    MicroRNA-21 (miR-21), Mutant Tumor Protein p53, and Matrix Metalloproteinase-9 (MMP-9) as Risk Markers for High-Grade Tumor Budding (HGTB) in Cervical Carcinoma: A Case-Control Study in a Balinese Population.
    Asian Pac J Cancer Prev. 2026;27:2931-2940.
    PubMed    
    Abstract available

  274. MILAMBO MJP, Giyosi N, Jafta Z, Ngxola N, et al
    Intersecting Burdens: HIV Prevalence and Cervical Cancer Progression Among Women in the Eastern Cape, South Africa: A Retrospective Descriptive Study.
    Asian Pac J Cancer Prev. 2026;27:2795-2801.
    PubMed    
    Abstract available

  275. URUNDAI MEERAN SB
    Enhanced Diagnosis of Cervical Cancer Using Archer Fish Hunting Optimizer-Optimized Xception Network with AI Interpretability via Grad-CAM.
    Asian Pac J Cancer Prev. 2026;27:2783-2793.
    PubMed    
    Abstract available

  276. AHMAD MU, Shaikh FN, Khan TM
    Methodological and Theoretical Considerations Regarding a Study on Cervical Cancer Screening Practices in Pakistan.
    Asian Pac J Cancer Prev. 2026;27:2747-2748.
    PubMed    


  277. JURIKOVA ZM, Hernychova L
    HPV infection and its significance in the development and prevention of cervical cancer.
    Klin Onkol. 2026;39:262-265.
    PubMed    
    Abstract available

  278. YASUKAWA M, Kohut A, Joseph DC, Miller J, et al
    Peri-treatment ctDNA dynamics in locally advanced cervical cancer: pilot study from a safety-net hospital.
    Gynecol Oncol Rep. 2026;66:102186.
    PubMed    
    Abstract available

  279. SAHU U, Singh S, Jain S, Samant M, et al
    Recent advancement in inflammatory biomarkers for cervical cancer diagnosis and therapy.
    Front Oncol. 2026;16:1806448.
    PubMed    
    Abstract available

  280. MEHTA A, Hegde AI, N P J, Velu U, et al
    Impact of qualitative Diffusion weighted imaging and apparent diffusion coefficient (DWI/ADC) on target volume delineation in cervical cancer: a feasibility study.
    Tech Innov Patient Support Radiat Oncol. 2026;39:100424.
    PubMed    
    Abstract available

  281. IQBAL H, Abuwatfa WH
    Immunological consequences of mesenchymal stem cell therapy in HPV-driven cervical cancer: a systematic review and stratification framework.
    Crit Rev Oncol Hematol. 2026 Aug 27:105570.
    PubMed    
    Abstract available

  282. GREGORY K, Iosua E, Signal V, Neumann R, et al
    Aotearoa New Zealanders' views of policies and funding for human papillomavirus vaccination and screening for cervical and lung cancers: a national survey.
    N Z Med J. 2026;139:69-78.
    PubMed    
    Abstract available

  283. YU W, Smith Z
    Sexual and Gender Minorities' Experience with Cervical Cancer Screening: A Systematic Review of Qualitative Studies.
    J Homosex. 2026 Aug 27:1-30. doi: 10.1080/00918369.2026.2715436.
    PubMed    
    Abstract available

  284. SONG J, Zhao Y, Dong C, Qi X, et al
    Bulk and single cell RNA sequencing data reveal lactylation-related gene signatures for prognosis and immunity in cervical cancer.
    Braz J Med Biol Res. 2026;59:e15368.
    PubMed    
    Abstract available

  285. SONAWANE K, Damgacioglu H, Amboree TL, Ford ME, et al
    Rates of Never Receiving Cervical Cancer Screening Among US Women, 2005-2023.
    JAMA Netw Open. 2026;9:e2631550.
    PubMed    


  286. MASOOD S, Rajawat J, Kumar M, Singh G, et al
    PARP1 genetic variants modulate gene expression and cervical cancer susceptibility in a North Indian case-control study.
    Mol Biol Rep. 2026;53:1470.
    PubMed    
    Abstract available

  287. CHAN HCC, Bhoora S, Zhou E, Marais S, et al
    Supraphysiological 25-Hydroxyvitamin D(3) and Calcipotriol Induce Reactive Oxygen Species, Mitochondrial Dysfunction and Apoptosis in HeLa Cervical Cancer Cells.
    FASEB Bioadv. 2026;8:e70144.
    PubMed    
    Abstract available

  288. MONDAL J, Chatterjee R, Gourisaria MK, Sahni M, et al
    Multi-plane attention guided 3D nnU-Net for MRI-based cervical cancer segmentation.
    Front Oncol. 2026;16:1862510.
    PubMed    
    Abstract available

  289. SHEN Y, Lu S, Zhao Q, Cui T, et al
    Targeting RSF1 with tanshinone I inhibits cervical cancer cell growth through modulation of NF-kappaB pathway.
    Front Pharmacol. 2026;17:1855194.
    PubMed    
    Abstract available

  290. PINTO V, Dellino M, Cerbone M, Di Naro E, et al
    The Role of Adjuvant Nonavalent HPV Vaccination After LLETZ in Patients with Isolated CIN2: A Controlled Cohort Study.
    Pathogens. 2026;15:814.
    PubMed    
    Abstract available

  291. GONZALEZ-TOLENTINO DL, Garibay-Cerdenares OL, Encarnacion-Guevara S, Martinez-Batallar AG, et al
    Molecular Insights from Differential Proteomic Profiling of Premalignant Cervical Lesions and Cervical Cancer.
    Pathogens. 2026;15:793.
    PubMed    
    Abstract available

  292. RONSINI C, Di Nuzzo A, Solazzo MC, Scaffa C, et al
    Exploratory Analysis of Systemic Inflammatory Indices Across Locoregional Tumor Progression Parameters in Cervical Cancer: The CERTIFIKO Prospective Study.
    Medicina (Kaunas). 2026;62:1570.
    PubMed    
    Abstract available

  293. ZIVADINOVIC AR, Petric AN, Zivadinovic LR, Ilic IR, et al
    Clinical Significance of High-Risk HPV Positivity with Negative Cytology: Can Further Evaluation Be Safely Delayed?
    Medicina (Kaunas). 2026;62:1493.
    PubMed    
    Abstract available

  294. TAIZHANOVA D, Serikbay N, Casas PHFDCL, Mijucic J, et al
    Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer.
    Int J Mol Sci. 2026;27:7302.
    PubMed    
    Abstract available

  295. PEPE L, Zuccala V, Giordano WG, Di Mauro G, et al
    Liquid Biopsy for Minimal Residual Disease Assessment in Endometrial and Cervical Cancers: Molecular Rationale, Clinical Evidence, and Translational Barriers.
    Int J Mol Sci. 2026;27:7155.
    PubMed    
    Abstract available

  296. PEREIRA GM, Calfa S, Santos PRD, Freitas AJA, et al
    MicroRNA Dysregulation in HPV-Driven Cervical Cancer: A Review of Oncoprotein-Targeted Signaling Pathways.
    Life (Basel). 2026;16:1332.
    PubMed    
    Abstract available

  297. VASQUEZ GUZMAN CE, Rosenkranz SJ, Martinez C, Layman KA, et al
    "It Feels Like They Cut off My Wings": Cervical Cancer Stories and Experiences Among Middle- to Older-Age Latina Survivors in the United States.
    Int J Environ Res Public Health. 2026;23:992.
    PubMed    
    Abstract available

  298. GIERULSKA N, Dabrowska Z, Jankowska N, Piekarz J, et al
    Targeted Anti-TF Antibody-Drug Conjugates in Advanced Cervical Cancer-Tisotumab Vedotin-Systematic Review.
    Cancers (Basel). 2026;18:2685.
    PubMed    
    Abstract available

  299. RAYA-BAHENA T, Rivera-Escobar RM, Hernandez-Gallegos E, Jimenez-Salazar JE, et al
    Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies.
    Cancers (Basel). 2026;18:2589.
    PubMed    
    Abstract available

  300. LIVERANI C, Boero V, Monti E, Caia C, et al
    Clinical Impact of HPV Self-Sampling and Molecular Biomarkers on Cervical Cancer Screening and Triage: "The Times They Are A-Changin'"-A Comprehensive Review and Future Perspectives.
    Cancers (Basel). 2026;18:2576.
    PubMed    
    Abstract available

  301. D'AVENIA M, Muhr LSA, Mastromauro M, Spadaccino F, et al
    Relative HPV Viral Load Measured by DeltaCt for Risk Stratification in Cervical Cancer Screening.
    Cancers (Basel). 2026;18:2568.
    PubMed    
    Abstract available

  302. YE Y, Fu Z, Wang X, Deng S, et al
    Study on the Expression Level of CAVIN3 Gene and the Prognosis of Radiotherapy in Patients with Cervical Cancer.
    Cancers (Basel). 2026;18:2551.
    PubMed    
    Abstract available

  303. KAMO N, Soeda S, Honda T, Fujimori K, et al
    Immune Absence as a Proposed Framework for Delayed Relapse After Curative-Intent Treatment in Human Papillomavirus-Associated Cervical Cancer.
    Cancers (Basel). 2026;18:2530.
    PubMed    
    Abstract available

  304. AOYAMA Y, Watanabe F, Tokutsu K, Muramatsu K, et al
    Association Between Japan's COVID-19 State of Emergency Declarations and Hospitalizations for Radiotherapy for Cervical Cancer.
    Tohoku J Exp Med. 2026 Aug 27. doi: 10.1620/tjem.2026.
    PubMed    


  305. MORADI S
    Addressing the hidden epidemic: the critical need for comprehensive psycho-oncology in cervical cancer.
    Evid Based Nurs. 2026 Aug 26:ebnurs-2026-104741. doi: 10.1136/ebnurs-2026-104741
    PubMed    


  306. SERGISON JE, Velickoff L, Hepler B, Knisley M, et al
    Trust-Building Across Levels of Care: A Conceptual Framework for Nursing Practice.
    ANS Adv Nurs Sci. 2026;49:105-111.
    PubMed    
    Abstract available

  307. LOUNIS M, Bencherit D, Abed M, Aissa ZB, et al
    Awareness and Knowledge Levels of Cervical Cancer and HPV and Attitudes Toward HPV Vaccination in Algeria.
    Vaccines (Basel). 2026;14:676.
    PubMed    
    Abstract available

  308. PATERNOSTRO C, Joura E, Nowotny G, Langthaler EM, et al
    Incidence and Risk Factors of Postoperative Bleeding After LLETZ.
    Med Sci (Basel). 2026;14:478.
    PubMed    
    Abstract available

  309. NATI ID, Mihu CM, Mihu D, Ciortea R, et al
    The Cervical Cancer Paradox in Eastern Europe: How Knowledge and Institutional Trust Shape HPV Vaccination Attitudes in Romania.
    Med Sci (Basel). 2026;14:431.
    PubMed    
    Abstract available

  310. NATI ID, Oancea M, Mihu CM, Mihu D, et al
    Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort.
    Med Sci (Basel). 2026;14:423.
    PubMed    
    Abstract available

  311. PRAPAN A, Aissara P, Soonthornchookiat P, Suwannasing C, et al
    Dihydroquinine Enhances Radiosensitivity in Cervical Cancer Cells Accompanied by Radiation-Induced Cellular Responses.
    Cells. 2026;15:1484.
    PubMed    
    Abstract available

  312. HU Y, Li J, Zhu S, Cheng L, et al
    Knowledge, Attitudes, and Practices Related to Radiotherapy and Chemotherapy Among Women with Cervical Cancer: A Cross-Sectional Study.
    J Multidiscip Healthc. 2026;19:624433.
    PubMed    
    Abstract available

  313. COLAK R, Kapar C, Tacar SY, Degerli E, et al
    Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey.
    Onco Targets Ther. 2026;19:622194.
    PubMed    
    Abstract available

  314. CHANG YC, McSweeney K, Xu Y, Liu Y, et al
    A Cell-Penetrating Peptide and Signal Sequence Fusion DNA Vaccine Enhances CD8+ T Cell-Mediated Anti-Tumor Immunity Targeting HPV-16 Cervical Cancer Antigens.
    Obstet Gynecol Res. 2026;9:54-63.
    PubMed    
    Abstract available

  315. GALVIS I, Hafeez A, Philip J, Salvatore M, et al
    The oncogenic role of mir-21 in cervical cancer: linking epithelial-mesenchymal transition to stromal remodeling.
    Front Oncol. 2026;16:1814515.
    PubMed    
    Abstract available

  316. BOTSUN P, Omelianenko I, Sava Y, Panko M, et al
    Cervical screening under wartime: resilience and quality of laboratory services in Ukraine during the Russian invasion.
    Front Public Health. 2026;14:1909774.
    PubMed    
    Abstract available

  317. FU Y, Du L, Zhang H, Wan J, et al
    Comprehensive analysis of senescence-associated secretory phenotype-related signature for predicting prognosis and immunotherapy response in cervical cancer.
    Comput Methods Biomech Biomed Engin. 2026.
    PubMed    
    Abstract available

  318. SIVAKUMAR I, Thirumalai J, Mohammed AAF
    Long-term trends and post-pandemic deviations in cervical cancer burden in South India, 1990-2023: a Global Burden of Disease 2023 study.
    Osong Public Health Res Perspect. 2026 Aug 26. doi: 10.24171/j.phrp.2026.0252.
    PubMed    
    Abstract available

  319. DERIBE KS, Shewaye S, Habtamu NS, Wondimagegnehu A, et al
    Multi-level determinants of comprehensive palliative care delivery for breast and cervical cancer patients in Ethiopia: using the socio-ecological model as an analytical framework.
    BMC Palliat Care. 2026;25:257.
    PubMed    
    Abstract available

  320. CHU HH, Tsai TC, Chen LH, Chang SD, et al
    Successful pregnancy outcome following fertility-sparing treatment for cervical cancer: A case report on the challenges of assisted reproductive techniques.
    Taiwan J Obstet Gynecol. 2026;65:995-999.
    PubMed    
    Abstract available

  321. SUN YH, Huang JY, Kuo ES, Yang SF, et al
    Long-term risk of cancer following cervical intraepithelial neoplasia: A significant study leveraging Taiwan's national health insurance research database.
    Taiwan J Obstet Gynecol. 2026;65:974-981.
    PubMed    
    Abstract available

  322. CHANG SH, Tang WJ, Chen WC, Chang CB, et al
    The addition of bevacizumab to combination chemotherapy in patients with recurrent, persistent, or metastatic cervical cancer: Aretrospective single-arm study.
    Taiwan J Obstet Gynecol. 2026;65:900-905.
    PubMed    
    Abstract available

  323. WANG PH, Yang ST, Kim JH
    The evolving treatment paradigm of locally advanced cervical cancer (LACC) recurrent, advanced, metastatic and persistent (RAMP) cervical cancer.
    Taiwan J Obstet Gynecol. 2026;65:880-884.
    PubMed    


  324. FANG MH, Wang KL, Lee J, Jan YT, et al
    Case report of an unusual cecal metastasis of a primary cervical squamous cell carcinoma.
    Taiwan J Obstet Gynecol. 2026;65:1008-1012.
    PubMed    
    Abstract available

  325. DABI Y, Martinez A, Lacorre A, Touboul C, et al
    SURGICAL NODAL STAGING IN CERVICAL CANCER, A NARRATIVE REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Aug 25:103260.
    PubMed    
    Abstract available

  326. CAI L, Jiang Y, Gu L, Li F, et al
    eIF3A Promotes the Warburg Effect in Cervical Cancer through m(6)A-dependent Translational Regulation of ENO1.
    Cancer Genet. 2026;308-309:15-29.
    PubMed    
    Abstract available

  327. BUIST DSM, Smith RA, Fendrick AM
    Aligning the stars: quality metrics must evolve from screening rates to diagnostic resolution.
    Am J Manag Care. 2026;32:376-379.
    PubMed    
    Abstract available

  328. SARVESWARAN G, Ramraj A, Sankarapillai J, Punathil S, et al
    Harmonization Framework for Translating Clinical Cancer Staging Systems for Public Health and Surveillance Use in Low- and Middle-Income Countries: Validation Using Indian Cancer Registry Data.
    Cancer Med. 2026;15:e72184.
    PubMed    
    Abstract available

  329. SHASHIKANT, Raghuvanshi R, Ali M, Meena H, et al
    Utility of Serum Vascular Endothelial Growth Factor and Its Clinico-Histopathological Correlation With Cervical Cancer: A Tertiary Care Centre Study.
    Cureus. 2026;18:e113209.
    PubMed    
    Abstract available

  330. ZHU M, Shen F, You J, Li J, et al
    Risk Factors for Occult Invasive Cervical Cancer in Women with Abnormal Cervical Screening and Infeasible Diagnostic Conization.
    Int J Womens Health. 2026;18:621098.
    PubMed    
    Abstract available

  331. REZA HM, Azhari HA, Chowdhury O, Bepari AK, et al
    Integrating pocket colposcope and telecolposcopy into VIA-based screening at primary healthcare centers for cervical cancer prevention in LMICs.
    Front Oncol. 2026;16:1902305.
    PubMed    
    Abstract available

  332. LIU Y, Yin D, Wu L, Wang H, et al
    Single-cell transcriptomics reveals a correlation between inflammatory C7 fibroblasts in cervical tumor-adjacent normal tissues and cervical cancer progression.
    Front Cell Dev Biol. 2026;14:1829843.
    PubMed    
    Abstract available

  333. YANG Z, Chen S, Liu X, Chen Y, et al
    Colorimetric analysis of metabolic biomarkers from unprocessed urine for rapid, at-home diagnosis of cervical cancer.
    Chem Commun (Camb). 2026 Aug 25. doi: 10.1039/d6cc03906.
    PubMed    
    Abstract available

  334. GUPTA RK, Shrestha K, Bhandari B, Manandhar B, et al
    Human Papillomavirus (HPV) Proportion and Genotype Distribution among Reproductive age Women of a Hilly District of Nepal.
    J Nepal Health Res Counc. 2026;24:109-115.
    PubMed    
    Abstract available

  335. WANG X, Wang F, Yang W, Li Y, et al
    Weighted Gene Co-Expression Network Analysis and Machine Learning Reveal that USP1 Drives Lipid Metabolism and Macrophage Polarization in Cervical Cancer Cells.
    Reprod Sci. 2026 Aug 24. doi: 10.1007/s43032-026-02172.
    PubMed    
    Abstract available

  336. YU P, Wei Y, Diao B, Sun C, et al
    STT3 promotes cervical cancer proliferation and apoptosis via PI3K/AKT pathway.
    Transl Oncol. 2026;72:102991.
    PubMed    
    Abstract available

  337. HOLT HK, Kislovskiy Y, Sawaya GF
    Cervical Cancer Screening Updates-Focus on Self-Collected Primary Human Papillomavirus Testing.
    JAMA Intern Med. 2026 Aug 24. doi: 10.1001/jamainternmed.2026.3980.
    PubMed    


  338. CHONGSUWAT T, Nana A, Ibrahim AO, Evensen AE, et al
    Assessment of Knowledge, Attitudes, and Practices around Cervical Cancer Screening in the Gulu District of Northern Uganda: A cross-sectional study.
    Int J Qual Health Care. 2026 Aug 24:mzag118. doi: 10.1093.
    PubMed    
    Abstract available

  339. GUO R, He W, Liu X, Zhang N, et al
    Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening.
    Anal Cell Pathol (Amst). 2026;2026:e6756766.
    PubMed    
    Abstract available

  340. ZHOU R, Wang H, Li A, Lv S, et al
    MicroRNA-135 alleviates cisplatin resistance in cervical cancer by inhibiting CD44v6.
    Pak J Pharm Sci. 2026;39:3500-3514.
    PubMed    
    Abstract available

  341. OU H, Chen W, Xiong Y
    HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer.
    Cell Signal. 2026;148:112840.
    PubMed    
    Abstract available

  342. XING T, Liu H, Yu W, Ren L, et al
    Drug Resistance and Therapeutic Reversal Strategies in Ovarian, Cervical, and Endometrial Cancers.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available

  343. GAO M, Wu L, Liu M, Liu W, et al
    Human Wings Apart-Like Protein as a Serum Diagnostic Biomarker in Cervical Cancer: An Integrative Bioinformatics Analysis with Serum Validation.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available

  344. LYU T, Li M, Li H, He L, et al
    Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study.
    Cancer Biomark. 2026;43:18758592261479724.
    PubMed    
    Abstract available

  345. USMANI S, Ahmed N, Burney IA, Kheruka S, et al
    Advances in Positron Emission Tomography Combined With Computed Tomography (PET/CT) Imaging in Cervical Cancer: From Metabolic Assessment to Fibroblast Activation Protein-Targeted Imaging.
    Cureus. 2026;18:e113158.
    PubMed    
    Abstract available

  346. RAJ EN, Li CJ, Cheng SH, Yong SB, et al
    Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer.
    Oncol Res. 2026;34:18.
    PubMed    
    Abstract available

  347. ZHAO D, Liu Q
    Cellular Immunotherapy for Cervical Cancer: Next Therapeutics Frontiers.
    Oncol Res. 2026;34:9.
    PubMed    
    Abstract available

  348. LIU C, Ji C
    AI-enhanced virtual screening identifies a potent small-molecule modulator of ClC-3 for cervical cancer drug discovery.
    Front Bioinform. 2026;6:1887419.
    PubMed    
    Abstract available

  349. GARG R, Agarwal K, Dhiman N, Gandhi G, et al
    Comparison of Conventional Pap Smear and Liquid-Based Cytology in the detection of Cervical Intraepithelial Neoplasia and Cervical Cancer.
    J Obstet Gynaecol India. 2026;76:291-297.
    PubMed    
    Abstract available

  350. CHEN X, Zhang L, Luo J
    Predictive value of triglyceride combined with age-adjusted D-dimer in patients with early-stage cervical cancer.
    J Int Med Res. 2026;54:3000605261476782.
    PubMed    
    Abstract available

  351. DENG X, Pang X, Dai Z
    Nursing intervention and follow-up compliance after abnormal cervical cancer screening.
    Medicine (Baltimore). 2026;105:e49893.
    PubMed    
    Abstract available

  352. TIBENDERANA JR, Kessy SA, Gimonge J, Peter I, et al
    Cervical cancer screening predictors in Tanzania: a variance component models' approach of national survey 2022.
    Medicine (Baltimore). 2026;105:e50260.
    PubMed    
    Abstract available

  353. ZHANG Q, Lin Y, Bao L, Huang Q, et al
    Analysis of the clinical utility of p16/Ki-67 dual staining in screening cervical lesions among women positive for high-risk HPV.
    Medicine (Baltimore). 2026;105:e50102.
    PubMed    
    Abstract available

  354. SHIN R, Shin A, Ramirez M, Bondre IL, et al
    Supporting patient understanding of cervical and ovarian cancer: how well does AI perform?
    Proc (Bayl Univ Med Cent). 2026;39:832-836.
    PubMed    
    Abstract available

  355. HAWKES D, Gurung D, Pineda E, Lee A, et al
    Clinical Validation of the Roche cobas and cobas 4800 Human Papillomavirus Tests on Self-Collected Vaginal Dry Swabs versus Practitioner-Collected Cervical Specimens Using the VALHUDES Protocol.
    J Mol Diagn. 2026;28:665-672.
    PubMed    
    Abstract available

  356. F G, J H, L SJ, P H, et al
    Association between body mass index and high grade cervical intraepithelial neoplasia (CIN 2/3) in a dysplasia referral population.
    Cancer Treat Res Commun. 2026;48:101279.
    PubMed    
    Abstract available

  357. HARRIS DA, Germano Toledo R, Hacker M, Wamakima B, et al
    Persistent or recurrent cervical dysplasia in women living with HIV after treatment for high-grade dysplasia in Botswana.
    AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004551.
    PubMed    
    Abstract available

  358. PEYDAYESH M, Nikfar S, Ghasemi K, Zamani N, et al
    Diagnostic performance of pap smear for cervical intraepithelial neoplasia in women with treatment-resistant vaginal infections: A colposcopy-guided biopsy correlated study.
    Cancer Treat Res Commun. 2026;48:101237.
    PubMed    
    Abstract available

  359. MONGE L, Blin A, Yousfi C, Mariotti S, et al
    [Preventing human papillomavirus in middle school: The role of an Escape Game].
    Gynecol Obstet Fertil Senol. 2026;54:417-424.
    PubMed    
    Abstract available

  360. AL AWFI MMM, Al Wahaibi ASIS, Arafa M, Al Badi H, et al
    Assessing telomerase and Ki-67 protein expression in pre-invasive lesions and invasive cervical neoplasia with correlation to clinico-pathological parameters.
    Clin Transl Oncol. 2026;28:3880-3896.
    PubMed    
    Abstract available

  361. TRUMPOUR T, Nasser J, Bax J, Gardi L, et al
    An Automated Mechatronic System for Registration of Three-Dimensional Ultrasound Images in Cervical Brachytherapy Procedures.
    IEEE Trans Biomed Eng. 2026;73:3249-3258.
    PubMed    
    Abstract available

  362. MCKENZIE AH, Zinzow HM, Kettrey HH, Baker AM, et al
    Barriers and Facilitators for Cervical and Breast Cancer Screenings Among Survivors of Gender-Based Violence.
    Health Commun. 2026;41:1811-1820.
    PubMed    
    Abstract available

  363. WAKUI N, Koakutsu Y, Watanabe M, Yokoyama Y, et al
    HPV Education and Its Impact on Vaccination Willingness and Recommendation Intentions Among Unvaccinated Japanese University Students: A Cross-Sectional Study.
    J Cancer Educ. 2026;41:787-793.
    PubMed    
    Abstract available

  364. RAI I, Karkala E, Borgaonkar R, Seide J, et al
    Call for Increased Community Education Regarding Common HPV-Associated Cancers Within the Urban Safety-Net Hospital Population.
    J Cancer Educ. 2026;41:753-761.
    PubMed    
    Abstract available

  365. KAYA FM, Ersoz S, Comba C, Demir O, et al
    Comparison of Cytological and/or Histopathological Results of Patients with Single and Multiple HPV Positivity.
    Acta Cytol. 2026;70:393-402.
    PubMed    
    Abstract available

  366. HANSEN J, Maclin BJ, Folmann B, Moller JE, et al
    Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study.
    Acta Obstet Gynecol Scand. 2026 Jul 27:10.1111/aogs.70311.
    PubMed    
    Abstract available

  367. AARNIO R, Ahuja V, Ryen L, Bergengren L, et al
    Balancing diagnostic accuracy and cost in the follow-up of histological low-grade squamous intraepithelial lesions.
    Acta Obstet Gynecol Scand. 2026;105:1871-1878.
    PubMed    
    Abstract available

  368. DE ARAUJO PONTES TH, de Souza ATB, Mendes-Aguiar CO, Silva MDPSNME, et al
    Cervical Cytokine Profile in High-Grade Squamous Intraepithelial Lesions.
    Cytopathology. 2026;37:523-530.
    PubMed    
    Abstract available

  369. ELEUTERIO JUNIOR J, de Souza VAA, Eleuterio RMN
    Psammoma Bodies in Cervical Liquid-Based Cytology of a Kyleena User.
    Cytopathology. 2026;37:564-565.
    PubMed    
    Abstract available

  370. TOYODA S, Morita K, Sado T
    Metaplastic-Like and Squamous Cell Carcinoma-Like Cells in Liquid-Based Cytology Associated With Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    Cytopathology. 2026;37:560-563.
    PubMed    
    Abstract available

  371. GRANADOS R, Duarte JA, Lujan DR, Gutierrez-Pecharroman AM, et al
    RNA Extended Interventional Nucleic Acid (REINA) Longitudinal Study: Decreased Risk of CIN2+/CIN3+ With Low-Grade Cytology After A Previous Negative HPV Test.
    Cytopathology. 2026;37:531-537.
    PubMed    
    Abstract available

  372. QIN Y, Gao H, Liao Y, Wu K, et al
    From HSIL to SCC: A Real-World Analysis of Diagnostic Upgrade Pathways and Pitfalls in Cervical Cytology.
    Cytopathology. 2026;37:538-543.
    PubMed    
    Abstract available

  373. JEONG Y
    Cervical Small Cell Neuroendocrine Carcinoma Initially Detected on Cytology: Diagnostic Pitfalls and Clues.
    Cytopathology. 2026;37:555-559.
    PubMed    
    Abstract available

  374. YILDIZ BE, Koc N
    Cytomorphologic Findings Associated With High-Risk HPV Categories in PAP Smears.
    Diagn Cytopathol. 2026;54:637-643.
    PubMed    
    Abstract available

  375. KONG Y, Cao T, Pan Q, Zhao D, et al
    Basaloid Squamous Cell Carcinoma of the Uterine Cervix: An Often Aggressive Subtype Frequently Underestimated by Cytology.
    Diagn Cytopathol. 2026 May 14. doi: 10.1002/dc.70145.
    PubMed    
    Abstract available

  376. MEEK JM, van Luijk IF, Gorris MAJ, Coens C, et al
    Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer.
    Eur J Cancer. 2026;246:116984.
    PubMed    
    Abstract available

  377. SHIN S, Yeo D, Kim H, Son Y, et al
    Age-specific burden of cervical cancer and attributable risk factors in Asia, 1990-2023: A global burden of disease study 2023.
    Eur J Obstet Gynecol Reprod Biol. 2026;326:115363.
    PubMed    
    Abstract available

  378. VERVALCKE J, Decaestecker K, Barouti K, Weyers S, et al
    Genital human papillomavirus detection in self-samples from transgender men.
    Eur J Obstet Gynecol Reprod Biol. 2026;325:115344.
    PubMed    
    Abstract available

  379. HANEDAN C, Nur Inal A, Koksal OK, Baydemir SK, et al
    vNOTES vs laparoscopic hysterectomy following conization with positive surgical margins: Surgical outcomes and postoperative HPV results.
    Eur J Obstet Gynecol Reprod Biol. 2026;325:115343.
    PubMed    
    Abstract available

  380. DAMEN JAA, Hoogendam JP, Idema DL, Lokerse ME, et al
    Macroscopic prediction of cervical dysplasia at colposcopy for see-and-treat patient selection: a systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2026;325:115330.
    PubMed    
    Abstract available

  381. HIJONA ELOSEGUI JJ, Hijona TR, Blanco AO, Carballo Garcia AL, et al
    Brushing versus curettage: Which is the best sampling mode in potmenopausal women with suspected endocervical pathology?
    Eur J Obstet Gynecol Reprod Biol. 2026;325:115290.
    PubMed    
    Abstract available

  382. JIANG A, Chen Y, Ma F, Zhang H, et al
    Malignant transformation risk and management dilemmas of atypical lobular endocervical glandular hyperplasia: A retrospective cohort study comparing Peutz-Jeghers syndrome versus sporadic cases.
    Gynecol Oncol. 2026;211:51-58.
    PubMed    
    Abstract available

  383. FENG P, Shi K, Zhao W, Zhang J, et al
    Diagnostic value of FAM19A4/SOX1/PAX1 methylation in non-16/18 high-risk HPV cervical lesions.
    Gynecol Oncol. 2026;211:37-45.
    PubMed    
    Abstract available

  384. SEO JH, Lee Y, Lim S, Chung YE, et al
    Dynamics of HER2 status in recurrent cervical cancer: Highlighting the clinical value of reassessment.
    Gynecol Oncol. 2026;212:125-133.
    PubMed    
    Abstract available

  385. KOCIAN R, Koehler C, Di Martino G, Klat J, et al
    Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study.
    Gynecol Oncol. 2026;212:106-115.
    PubMed    
    Abstract available

  386. RIESE C, Yi-Tung E, Nilsson H, Salehi S, et al
    Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).
    Gynecol Oncol. 2026;212:152-159.
    PubMed    
    Abstract available

  387. ARMAROLI P, Zappa M, Giorgi Rossi P, Carozzi FM, et al
    Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening.
    Int J Cancer. 2026 May 5. doi: 10.1002/ijc.70536.
    PubMed    
    Abstract available

  388. MURTAS M, Vassilakos P, Wisniak A, Hu K, et al
    Resource-Adapted Triage Strategies for Women Testing HPV Positive With Self-Collected Vaginal Samples in Cameroon.
    Int J Cancer. 2026 Jun 18. doi: 10.1002/ijc.70573.
    PubMed    
    Abstract available

  389. MOUFARRIJ S, Pareja R, Fletcher A, Wilailak S, et al
    De-escalating radical surgery for select FIGO Stage I cervical cancer.
    Int J Gynaecol Obstet. 2026 Jul 27. doi: 10.1002/ijgo.71230.
    PubMed    
    Abstract available

  390. LANG M, Dang L, Zhang S, Zhu L, et al
    Association between Composite Dietary Antioxidant Index and cervical cancer: A population-based cross-sectional study.
    Int J Gynaecol Obstet. 2026 Aug 19. doi: 10.1002/ijgo.71276.
    PubMed    
    Abstract available

  391. SHEN J, Liao J, Wang J, Xing H, et al
    Automated acquisition of explainable knowledge from unannotated colposcopic images for predicting the natural course of CIN2.
    Int J Gynaecol Obstet. 2026;174:1547-1558.
    PubMed    
    Abstract available

  392. LANDMAN Y, De Sousa Smith C, Ke S, Roumeliotis M, et al
    Image-guided brachytherapy for locally advanced cervical cancer: clinical outcomes and fistula risk in stage IVA disease.
    Int J Gynecol Cancer. 2026;36:104848.
    PubMed    
    Abstract available

  393. MARTINS JC, Simonsen M, Salim RC, de Azevedo Focchi GR, et al
    Lymphovascular space invasion in cervical cancer: beyond the binary.
    Int J Gynecol Cancer. 2026 Jul 11:104864. doi: 10.1016/j.ijgc.2026.104864.
    PubMed    


  394. CASARIN J, Bianchi T, Torri V, Melazzini MG, et al
    Surgical volume, structural quality, and compliance with European Society of Gynaecological Oncology quality indicators in endometrial and cervical cancer: a regional cross-sectional assessment.
    Int J Gynecol Cancer. 2026;36:104847.
    PubMed    
    Abstract available

  395. EL HAJJ H, Gouy S, Limkin E, Scherier S, et al
    Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?
    Int J Gynecol Cancer. 2026 Jul 15:104874. doi: 10.1016/j.ijgc.2026.104874.
    PubMed    


  396. IGA K
    Inconclusive, not reassuring: reporting low-risk cervical cancer surgery outcomes.
    Int J Gynecol Cancer. 2026 Jul 31:104887. doi: 10.1016/j.ijgc.2026.104887.
    PubMed    


  397. MARTINS JC, Gomes Silva BG, de Mello Graziano L, Scaranti M, et al
    Does timing matter? Rethinking immunotherapy strategies in locally advanced cervical cancer.
    Int J Gynecol Cancer. 2026 Aug 4:104944. doi: 10.1016/j.ijgc.2026.104944.
    PubMed    


  398. CHILINDA GK, Meja SJ, Kocian R, Mirandola M, et al
    Implementation of a gynecologic oncology ultrasound training program to support cervical cancer staging at Queen Elizabeth Central Hospital in Malawi.
    Int J Gynecol Cancer. 2026;36:104906.
    PubMed    
    Abstract available

  399. SEKAR P, Vulysteke P, Ntloedibe T, Bvochora-Nsingo M, et al
    Pace of Cervical Cancer Stage Progression Prior to Radiation Therapy Initiation, an Instrumental Variable Analysis.
    Int J Radiat Oncol Biol Phys. 2026 Aug 12:S0360-3016(26)04139.
    PubMed    
    Abstract available

  400. AHN SH, Bhutta ZA, Na H, Lee HK, et al
    Anticancer effects of tangeretin associated with reactive oxygen species generation, mitochondrial dysfunction and apoptosis in CaSki cells.
    Oncol Rep. 2026;56:166.
    PubMed    
    Abstract available

  401. TSUCHIDA K, Ogawa K, Toita T, Ikushima H, et al
    Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1/JGOG1088S).
    Radiother Oncol. 2026 Aug 27:111752. doi: 10.1016/j.radonc.2026.111752.
    PubMed    
    Abstract available

  402. EIDBUR A, Atjimakul T
    External validation of predictive models for high-grade cervical lesions in Thai women undergoing colposcopy: a retrospective external validation study.
    BMC Cancer. 2026;26:960.
    PubMed    
    Abstract available

  403. ZHANG Y, Chen S, Jiang Y, Zhang L, et al
    A combined PAX1/JAM3 methylation and HPV viral load model for exploratory risk stratification of >/=CIN2 among women with positive cervical screening results.
    BMC Cancer. 2026;26:1029.
    PubMed    
    Abstract available

  404. CHEN R, Gan Q, Zhao S, Zhang D, et al
    Retraction Note: DNA methylation of miR?138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    BMC Cancer. 2026;26:1026.
    PubMed    


  405. LONG C, Wang S, Wang Y
    SPP1 promotes cisplatin resistance in cervical cancer by regulating KRAS expression.
    PLoS One. 2026;21:e0353621.
    PubMed    
    Abstract available

  406. JOHN A, Rasheed R, Idikula MJ
    Perceptions and practices among students, parents, and teachers of the Human Papillomavirus (HPV) Vaccination: A pilot feasibility study from Rural Kerala.
    PLoS One. 2026;21:e0340559.
    PubMed    
    Abstract available

  407. YANG H, Tan Y, Pang Y, Chen X, et al
    Efficacy comparison of concurrent chemoradiotherapy alone versus concurrent chemoradiotherapy plus adjuvant chemotherapy in stage III Locally Advanced Cervical Cancer: A single-center, retrospective observational cohort study.
    PLoS One. 2026;21:e0354207.
    PubMed    
    Abstract available

  408. KWESI-MALIEPAARD EM, Osea-Larbi JA, Nyamari CK, Alhassan Y, et al
    Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya.
    PLoS One. 2026;21:e0355868.
    PubMed    
    Abstract available

  409. JIA M, Song Y, Shang J, Zhuang L, et al
    An interpretable Hallmark pathway activity classifier for distinguishing CIN3/HSIL from invasive cervical squamous carcinoma: Development, external validation, and feature stability assessment.
    PLoS One. 2026;21:e0356465.
    PubMed    
    Abstract available

  410. DENG Q, Wang Z, Zhao J, Li N, et al
    HDAC2 restrains IGF2BP1-associated m6A dysregulation in cervical cancer immunotherapy resistance.
    PLoS One. 2026;21:e0355606.
    PubMed    
    Abstract available

  411. MOSTAFA HH, Fall A, Gaillard S, Fakhry C, et al
    Application of Cobas 6800 HPV testing and qPCR utilizing three genomically-optimized primer sets for detecting HPV DNA in the blood of HPV Positive dysplasia and cancer patients.
    PLoS One. 2026;21:e0354671.
    PubMed    
    Abstract available

  412. LIU X, Shrestha SK, Edwards YJK, Filippova N, et al
    HuB/HuR inhibition decreases HPV E6 and E7 proteins, stabilizes p53, and induces integrated stress to impair cervical cancer cell growth.
    Proc Natl Acad Sci U S A. 2026;123:e2401248123.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;